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Abstract 
 
Polylactic acid (PLA) is a versatile biopolymer that is widely used as a biomaterial. 
However, one of the major issues which limits its further application in tissue engineering 
purposes is its hydrophobic nature and poor cellular interaction. Modification of PLA 
properties can be achieved by polymer blending techniques. Polymer blending is a simple 
yet attractive method to combine and optimize polymeric physical properties of interest. 
In this study, an antibacterial electrospun nanofibrous scaffolds, with diameters around 
400–1000 nm, were prepared by physical blending PLA with a hydrophylic biopolymer, 
cellulose acetate (CA). In this stage, PLA was used as the main polymer, blended with 
CA, at two main ratios (9:1 and 7:3 w/w), to achieve desirable properties such as better 
hydrophilicity, excellent cell attachment and proliferation. For preventing common 
clinical infections, an antimicrobial agent, Thymoquinone, TQ was incorporated into the 
electrospun fibers. TQ is the active ingredient of Nigella sativa and it is well known for 
its antibacterial properties. The potentiality of the prepared scaffolds, regarding being 
used as an interactive wound dressing, has been investigated including, swelling 
behavior, WVP and porosity.  The release profile of TQ from the prepared scaffolds was 
also examined at the physiological pH (7.4) and temperature (37 οC). The antimicrobial 
efficiency of the prepared scaffolds against gram negative and gram positive bacteria 
were determined by the agar diffusion assay. The interaction between fibroblasts and the 
TQ-loaded PLA: CA scaffolds such as viability, proliferation, and attachment were 
characterized. TQ-loaded PLA: CA scaffolds showed burst TQ release after 24 h, 
compared with medicated PLA scaffolds, followed by a sustained release rate for 9 
successive days. The results also indicated that medicated PLA: CA nanocomposite 
scaffolds showed a significant antibacterial activity against both gram positive and gram 
negative bacteria. Furthermore, the prepared scaffolds enhanced cell viability, attachment 
and proliferation, as compared to medicated PLA nanofibers.  The presence of CA in the 
nanofiberous scaffolds improved its hydrophilicity, bioactivity, and water uptake 
capacity. Furthermore, it created a moist environment for the wound, which can 
accelerate wound recovery. A preliminary in vivo study performed on normal full 
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thickness mice skin wound models demonstrated that TQ-loaded PLA: CA (7:3) 
scaffolds significantly accelerated the wound healing process by promoting angiogenesis, 
increasing re-epithelialization and controlling granulation tissue formation. Our results 
suggest that TQ-loaded PLA: CA nanocomposite mat could be an ideal biomaterial for 
wound dressing applications. 
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Introduction 
 
1.1 Chronic Wounds: clinical complications 
Skin, the largest organ of the body, consists of different types of tissues including: 
connective, nervous, muscular, and epidermal. Such composition is responsible for the 
multifunctional properties of the skin. Skin not only responsible for sensation or physical 
protection of the body, but it can also perform number of biochemical, metabolic and 
immune functions. When our skin barrier is disrupted through chronic wounds, a series of 
complex physiochemical process takes place in an attempt to repair the damage. Such 
processes can be classified into inflammatory reactions (immune response to prevent 
infection) and proliferative reactions (regeneration of tissues) [1].  
Chronic wounds are defined as the wounds that do not show a 20–40% reduction in area 
after two to four weeks of treatment. Such delay is chronic wounds fail to heal through the 
natural physiological processes described before. This is attributed to the fact that all 
chronic wounds are characterized by one or more persistent inflammatory stimuli, 
including; repeated trauma, or ischemia. Such inflammatory stimuli are continues and 
never overcome, thus impair the physiological progression toward healing. The most 
common chronic wounds are diabetic foot ulcers, pressure ulcers, venous leg ulcers, and 
arterial leg ulcers. In most patients, the origins of delayed healing comes from a metabolic 
dysfunction such as obesity, diabetes, malnutrition or, immunological defects due to 
genetic defects or cancer [1, 2].  
Chronic wounds are highly susceptible to the risk of bacterial infection. This is because the 
longer the wound remains opened and unhealed, the more likely it will be colonized by 
microorganisms coming from different sources (external environment, surrounding skin, 
and endogenous sources). Chronic wound infections not only increase patient discomfort 
or cause anxiety, but it can also lead to high risk of systemic illness. This is attributed to 
the fact that when the pathogens enter chronic wounds, they develop infection by the 
formation of a biofilm. Within the biofilm, bacteria is isolated form the immune system 
and can develop high resistance against antibacterial agents. Thus, it can result into 
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systemic infection which can further complicate illness. For that reason, chronic wound 
infections can be considered as the main causes of mortality and morbidity in developing 
countries [2-4]. 
 
1.2 Nanofiberous membranes as wound dressing 
material.  
Ideal wound dressing for complicated chronic wounds must not only act as a physical 
barrier against mechanical trauma, it shell also accelerate the healing process, preventing 
bacterial infections and allowing skin to restore its structure (Figure 1.1).   
 
 
 
Figure 1.1:  Requirements for an effective wound dressing material [5]. 
 
Conventional wound dressings that are commercially available including, natural or 
synthetic bandages, cotton wool, lint, and gauze, do not meet the properties required for 
rapid healing of chronic wounds. They act as a cover to the wound and do not have any 
special properties, such as gas permeability, water uptake (limited swelling capacity) or 
bacterial infiltration. When it comes to chronic wounds, such poor performance can result 
in delaying the healing process, or even in more complications, such as causing 
ischemia/necrosis [3, 5]. 
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A multifunctional device that is able to treat different types of chronic wounds by 
minimizing the risk of infection and wound recurrence is not currently available to patients. 
Research in this field currently focuses on developing dressings that can combine two 
essential properties: First, is to control the physiological parameter on which the healing 
process is based. This includes the gas and moisture permeability and exudates adsorbing 
capacity. Second, is to incorporate an antibacterial agent with a controlled release manner. 
A wound dressing that is capable of delivering all these requirements would both stimulate 
the healing process while preventing infections. This class of wound dressing materials can 
be classified as the bioactive dressings. Bioactive dressings include those incorporating 
drug delivery systems skin substitutes, and growth factors. Consequently, they can play an 
active role in the healing process by activating or driving cellular responses. Bioactive 
dressings represent an essential step forward toward the development of effective systems 
capable of delivery an accelerated healing for chronic wounds while eliminating their 
clinical complications [3, 6-8]. However, research is still very intensive in this regard. 
 
1.2.1 Nanofibers Properties 
Polymeric Nanofibrous meshes refers to the structures made of ultra-fine polymeric fibers. 
The diameters of such fibers ranges from several micrometers down to few nanometers. 
Such very small diameter results in a relatively high surface area to volume ratio 
(approximately 100m2/g for a fiber with a diameter 100 nm) [9]. The increase in surface 
area per unit ratio can greatly alter the physio-chemical and morphological properties of 
the obtained nanofiber mats including:  
High porosity and small pore size: The way nanofibers are synthesized allow self-
assembled nanofibers to align themselves into a characteristic 3D pattern, such as a 
honey comb meshes. Because of the small fiber diameter and high surface area to 
volume ratio, tiny pores in the range of 0.5 nm are formed within the nanofiber mesh, 
resulting in highly porous 3D structure (Figure 1.2) [9][10]. 
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Figure 1.2: SEM micrographs showed highly porous structure with interconnected pores and 
bead-free PCL NFs [9]. 
 
 
Owing to their several intrinsic properties, including high surface area to volume ratio and 
high porosity, research drivers in the field of wound care development are now focusing 
on the manufacture of wound dressings in the form of nanofibrous membranes. Such 
unique properties allow them to satisfy the essential requirements for an ideal wound 
dressing material [9]. 
 
1- Accelerating wound healing: for the wound dressing material to accelerate wound 
healing, it needs to support cellular attachment, migration and proliferation to 
encourage tissue regeneration. Nanofibrous structure has the ability to support 
cellular growth. This is attributed to their unique structure that mimic the structure 
of the extracellular matrix (ECM). ECM is the non-cellular component present 
within all tissues. It is characterized by being a 3-D structure with high porosity, 
and sufficient mechanical properties. Thus, it acts as a natural scaffolds that 
physically support cells and provide them with the conditions required for 
attachment, proliferation, migration and differentiation. Nanofiberous membranes 
can offer an ideal alternative for the native ECM that has been destroyed by injury. 
Owing to their 3-D structure nano-size and high porosity, it can imitates the 
architecture of the native ECM.  Furthermore, it can act as a synthetic scaffolds that 
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can further reproduce the structure of the natural injured ECM. Another advantage 
is the ability to electrospun natural polymers, such as protein and polysaccharides. 
ECM in its composition, includes interconnected structures of proteins (keratin, 
collagen and elastin), polysaccharides (glycoaminoglycans). Thus, the ability to 
incorporate natural components within the fibrous mesh can further improve 
biocompatibility and cellular response [3, 5, 7, 11]. 
 
2- Gas and water vapor permeability: An essential parameter in the healing process 
is the permeability of the wound dressing to air. High permeability to air result in 
better healing performance, since it allow for cellular respiration. The water vapor 
permeability is also essential, because moisture can also accelerate the healing 
process. Nanofibrous structure shows high porosity (60-90%). Thus it can allow for 
cellular respiration and high gas and moisture permeation [3, 11, 12, 13]. 
 
3- Absorbing excess wound exudates: Moisture is an essential factor in wound healing. 
However, the presence of high amount of fluids in wound beds can further 
accelerate bacterial colonization.  An ideal wound dressing material must provide 
sufficient amount of moisture to avoid wound dehydration while being able to swell 
and absorb excess secretions in wound bed. The high surface area and inter-
connected pores in the nanofiberous mesh structure allow them to absorb fluids [3, 
4, 11]. 
 
  
4- Obstructing or preventing bacterial invasion: beside their high porosity, the size 
and dimensions of the pores is also an advantage for nanofibrous meshes. 
Nanofibrous structure have pores within the nanometers. The average diameter of 
spherical bacteria is 0.5-2.0 µm. For rod-shaped or filamentous bacteria, length is 
1-10 µm and diameter is 0.25-1 .0 µm. On the other hand, the approximate pore 
size diameter of nanofibrous mesh is 0.5 nm. Such minute size can prevent 
microbial infiltration from the external environment. Also, the ability to introduce 
bioactive agents during the fabrication process can further allow for incorporating 
antibacterial drugs within the mesh structure [3][11].  
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1.2.2 Nanofibers fabrication: Electrospinning technology 
Various techniques are available for the fabrication of nanofibrous meshes, however, 
electrospinning is the most common technique used and this is attributed to number of 
advantages outlined in this sections. 
 
Compared with other fabrication techniques, including phase separation and self-assembly, 
electrospinning provides a simple and cost-effective way to produce nanofibrous meshes 
with fiber diameter in the nanometer range. The main advantage for the electospinning 
technique beside its feasibility is that a wide range of polymers can be used. There are 
many natural polymers that were used fabricated into nanofibers in the sub-micron range 
using the electrospinning technique. This natural polymers includes proteins, such as 
collagen and gelatin, and polysaccharides, such as cellulose and its derivative cellulose 
acetate. This is considered an advantage when it comes to biomedical applications because, 
for biological purposes, the materials used need to be biocompatible. The two main classes 
of polymers that are used for biomedical applications are either natural polymers or 
biocompatible synthetic polymers, such as poly (β carpolactone) and poly (lactic acid). 
Another advantage for electrospinning is that it allows the combination of different 
synthetic and natural polymers to fabricate nanofiberous membranes of tailered properties. 
The possibility of large-scale production combined with simplicity and versatility makes 
the electrospinning technique very attractive for a wide range of applications [3, 9, 14, 15, 
16, 17] 
 
A typical electrospinning setup (Figure 1.3) consists of a high voltage power supply (up to 
30 KV), a pump, to adjust the flow rate of the polymer solution, a syringe connected to a 
capillary needle through which the polymer solution pass, and a collector. The needle tip 
is connected to one electrode of the power supply, while the collector is connected to the 
opposite electrode. The basic principle for the electrospinning technique depends on 
applying a high voltage to a polymer droplet hanged at the needle tip. Such voltage will 
electrify the polymer molecules within the droplets with the same charge. Consequently, 
electrostatic repulsion will take place which will result in the deformation of the polymer 
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droplet, forming a cone (taylor cone). Finally, polymeric jet ejects from the deformed one 
and moves toword the oppositely charged collector. During its journey, the solvent 
evaporates and the polymer jets finally deposit in the form of ultra-fine fibers mesh on the 
surface of collector. The basic configuration shown in figure is used for the fabrication of 
non-woven meshes composed of randomly aligned fibers [3, 14, 16, 18]. 
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Figure 1.3:  Schematic representation of electrospinning basic set up. a) Image of Taylor cone 
forming at the spinneret during the electrospinning process. b) Image of polymeric filament 
forming from Taylor cone and moving toward the collector [3]. 
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1.3 Components of an effective wound dressing 
nanofibers 
A wide range of polymers can be used to obtain ultrafine nanofibers in the submicron range.  
In the last decade, more than 200 polymers have been electrospun and characterized 
successfully to be introduced for different applications. When it comes to wound dressing 
applications, biopolymers become of huge interest. Also, an effective nanofiberous 
scaffolds, targeting wound care purposes, shell also include an active ingredient that can 
further enhance the healing process. Such active ingredient could be an antibacterial agent, 
or a growth factor [3, 19].   
 
1.3.1 Biopolymers 
Biopolymers are class of polymers that are produced by living organisms. Thus, they are 
considered as polymeric biomolecules. Biopolyermers are widely used in number of 
biomedical applications, owing to their high cyto-compatability. Biopolymers can be sub-
divided into two main categories: First, is the biodegradable polymers, derived from 
renewable and non-renewable resources. Second, is the materials that are non-
biodegradable but derived from renewable resources. Biodegradable biopolymers are 
defined as those that undergo microbial induced chain scission leading to their 
mineralization. Biodegradable Biopolymers can be further sub-divided into two main 
groups. One group contains the biodegradable petroleum-based polyesters such as Poly-
caprolactone (PCL). The other group contains polymers from common natural and 
renewable resources, like the thermoplastic starch, cellulose and cellulose derivatives, or 
poly-lactic-acid (PLA) [20, 21, 22].  
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 1.3.1.1 Poly-lactic acid: Structure, synthesis and applications 
 
Structure. Polylactic acid or polylactide (PLA) is the polymer of lactic acid. It represent a 
linear thermoplastic aliphatic polyester that is derived from natural and renewable 
resources, such as corn starch, tapioca roots, and sugarcane. It exists in two optical forms 
(Figure 1.4), L (+) Polymer and D (-) polymer. Both isomers are partially crystalline, while 
the racemic poly (D, L-lactic acid) is amorphous [23,24].  
 
Synthesis. PLA is synthesized by a two-step process consisting of fermentation, for 
production of lactic acid form the plant base, and chemical process for polymerization. 
Generally, there are two methods for PLA polymerization process (Figure 1.5).  
 
Figure 1.4: Chemical structure of poly-lactic acid (PLA) and its constituent monomers [23]. 
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- Direct condensation polymerization: This reaction refers to the direct condensation 
of lactic acid and it can be considered the least expensive route of synthesis. Low 
molecular weight (MW) PLAs (< 3 000 g/mol) can be produced easily by direct 
condensation. However, one of the main drawback of this process is that it cannot be 
used for the synthesis of high molecular weight PLA. This is because the reaction 
taking place is an equilibrium reaction with water produced as by-product. Thus, it is 
essential to remove water continuously to drive the reaction forward. In this regards, 
it is very difficult to obtain a solvent-free high molecular weight polymer by this route. 
In order to overcome such limitation, chain coupling agents are used, which further 
adds cost and complexity to the process.  
 
- Polymerization through lactide formation: lactide is a cyclic dimer that is produced 
by the dehydration of lactic acid. First, lactic acid is pre-polymerized to obtain low 
molecular weight (MW) PLA as an intermediate. Second, the intermediate PLA is 
catalytically depolymerized through an intramolecular trans-esterification reaction to 
produce the cyclic lactide. Finally, cyclic lactide undergoes ring-opening 
polymerization to form the high (MW) PLA [20, 23, 24]. 
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Figure 1.5: Different techniques for the synthesis of Poly-lactic acid. [23] 
 
 
Properties and Applications. PLA is a hydrophobic polymer with limited solubility is 
water and common alcohols, such as ethanol. The methyl group in the lactic acid is 
responsible for such hydrophbicity. It is also presents a steric hindrance that is responsible 
for the high solubility of PLA in organic solvents. Although, low molecular weight PLAs 
are partically hydrophilic and contain oligomers with some aqueous solubility. The 
presence of ester linkages in the polymer backbone (Figure 1.4.) allows hydrolytic 
degradation of the polymer in an aqueous environment. The degradation rate is dependent 
on several parameters such as crystallinity (crystalline PLA degrades slower), molecular 
weight (MW) (low MW PLAs degrade faster) environment (pH, ionic strength, 
temperature) and particle morphology (porous structures degrade faster) [24, 25, 26]. 
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In 2010, PLA was the classified as the second most important bio-plastic in the world 
regarding its consumption volume. Owing to their desirable properties, Polylactic acid 
(PLA) has been considered as a good alternative to petroleum-based plastic in food and 
medical application.  Such properties includes biodegradability (PLA is 100% 
biodegradable), renewability (PLA can be recycled over 7-10 times), biocompatibility, and 
low toxicity to humans. The degradation products, resulting from PLA aqueous hydrolysis, 
are biocompatible and metabolizable; they are removed from the body by the citric acid 
cycle. Of the two PLA enantiomers, the polymeric L-lactic acid is commonly used because 
it can be degraded into the endogenous lactic acid produced by the body. Also PLA 
possesses enhanced physical properties such as transparency, good thermal, mechanical 
properties, and good processing properties [23, 24, 25]. 
 
With their excellent biocompatibility, polylactic acid (PLA), as well as its copolymers with 
glycolic acids (PLGA), are becoming the most commonly used synthetic biodegradable 
polymers in the medical field. PLA was approved by the US Food and Drug Administration 
in the 1970s and since has been widely employed in sutures, clips, plates and screws, in 
drug delivery devices, and in food packaging applications [25]. 
 
 
1.3.1.2 Cellulose acetate: structure, synthesis and applications 
 
Structure. Cellulose acetate (CA) is ester form of cellulose. Cellulose is a natural polymer, 
consisting of anhydroglucose as repeating units, and has three hydroxy groups per unit 
(Figure 1.6). Cellulose acetate can be easily obtained from natural resources and recycled 
in environment by biodegradation. CA with different properties are obtained depending on 
the esterification degree (degree of substitution). The degree of substitution is also 
expressed as acetyl value (combined acetic acid (%)) [27, 28]. 
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Synthesis. Cellulose acetate is produced through two-step reactions involving: i) the 
esterification of acetic acid with cellulose and ii) the partial hydrolysis of the resultant ester 
groups (Figure 1.7). The synthesis process starts by the activation of raw cellulose by a 
pre-treatment step. Usually wood pulp or cotton linters are used as the cellulose raw 
material. In the subsequent step, acetylation reaction takes place by adding acetic anhydride 
or acetic acid to the pretreated cellulose. Sulfuric acid is used as a catalyst to carry out the 
esterification reaction. In the acetylation step, cellulose triacetate is generated, in which 
almost all the hydroxy groups have been esterified. The final step, known as the ripening 
step, water is added to the prepared cellulose triacetate. This results in the partial 
hydrolyzes of the ester groups to result in cellulose acetate with a desired acetyl value [29, 
30]. 
 
Properties and applications. CA is highly hydrophilic, with good liquid transport and 
water absorption abilities. It can be easily fabricated into films, membranes and fibers. CA 
has been widely used in membranes for separation and medical application because of its 
advantageous properties, such as good biocompatibility, biodegradability, regenerative 
properties, high affinity with other substances, high modulus, and adequate flexural and 
tensile strength  [28,29]. 
 
Figure 1.6: Chemical structure of cellulose acetate [27]. 
 16 | P a g e  
 
 
Figure 1.7: Chemical synthesis of cellulose acetate polymer [29]. 
 
1.4. Natural extracts in nanofibrous wound dressings  
As it was mentioned previously, active ingredients are widely used with in the nanofiberous 
membranes to prepare an interactive scaffolds for wound care. A main class of active 
ingredients is the natural products, especially plant and herbal extracts. By understanding 
the pharmacology of many ancient medicinal herbs increases day by day, the importance 
of alternative medicine also increase.  Alternative medicine has gained more attention in 
modern science. Research has proved that herbal medicine can exert their medicinal effect 
on the human body through mechanisms identical to those already understood for chemical 
compounds in conventional drugs. In other words, herbal medicines do not differ greatly 
from conventional drugs regarding how they work. Thus, herbal medicines can be as 
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effective as conventional medicines. Various naturally occurring compounds are now used 
effectively as therapeutics agents such as the antimicrobial drug penicillin and the widely 
used chemotherapeutic agent, paclitaxel {31, 32, 33] 
 
Thymoquinone (TQ), a phytochemical found in the volatile oil of Nigella sativa seeds, has 
shown potential as a novel therapeutic agent. The seeds have been used as a folk remedy 
for various ailments for thousands of years. The presence of rich biological active 
compounds in Nigella sativa volatile oil has highlighted its traditional medicinal use. Many 
active principles have been isolated from Nigella sativa seed, however, the most important 
ingredient, responsible for its medicinal properties, is the Thymoquinone (TQ). TQ (2-
isopropyl-5-methyl-1, 4-benzoquinone) (Figure 1.8), shows a wide range of biological 
effects including: antibacterial, anti-cancer, anti-diabetic, and anti-inflammatory effects. 
TQ has low solubility in aqueous medium, which further limit its bioactivity. A lot of 
studies has been done on its medicinal properties [34, 35].   
 
 
Figure 1.8: chemical structure of Thymoquinone, active principle of Nigella Sativa [34]. 
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2 Literature review 
 
2.1 Functional nanofibrous scaffolds for wound 
dressing applications 
The initial phase of research for the fabrication of nanofibers-based wound dressing 
materials mainly focused on optimizing the different parameters of the electrospinning 
process in order to achieve the desired morphological, physico-chemical, and mechanical 
properties. The following phase of research aims at creating more advanced nanofibrous 
devices that is able to encourage the healing process and prevent infection. In this regard, 
wound dressing based on nanofibrous meshes can be classified into three main categories: 
passive; interactive and advanced. This classification reflects the evolution of nanofirous 
wound dressings in terms of the selected materials, technique of fabrication, and 
functionalization of the fibers [3].  
 
2.1.1 Passive Electrospun Meshes 
Passive electrospun meshes are defined as the dressing material that can provide the 
minimal morphological and physical properties required for the healing process. This 
includes small diameter (within the nano-range), adequate membrane proposity, and gas 
and moisture permeability. Such system can maintain suitable levels of moisture in the 
wound bed and protect tissues from mechanical trauma. Passive electrospun meshes are 
fabricated from both natural and synthetic polymers [3].  Khil et al. successfully fabrictaed 
electrospun poly (urethane) membranes [36]. The morphological characterization and in 
vivo experiments showed that the matrix could be employed as wound dressings. Also, 
Phachamud and Phiriyawirut suggested the potential use of poly (vinyl alcohol) (PVA) 
fibers as wound dressing because of their swelling behavior and uniform fiber diameter 
[3]. Uppal et al. optimized the electrospinning conditions for the fabrication of hyaluronic 
acid (HA) nanofibrous [37]. In vivo studies indicated that the e-spun membranes offered 
the best treatment of full-thickness wounds when compared with four types of commercial 
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dressings (adhesive bandage, a sterilized HA film, gauze with Vaseline and an antibiotic 
dressing). 
 
2.1.2 Interactive Electrospun Meshes 
Interactive electrospun meshes combines the morphological and physical properties 
required for wound healing with the added value of being able to induce optimal cell 
responses and limit bacterial infiltration in the wound bed. The main strategy utilized to 
achieve such purpose is the combination of synthetic polymers and biopolymers. Synthetic 
polymers ensure easy processability and good mechanical properties for the mesh, while 
natural polymers improve the biocompatibility of the mesh so that it can actively interact 
with biomolecules involved in the healing process. Such combination targets the 
production of a multicomponent system more closely mimic the ECM (extracellular 
matrix). The main strategy used for combining natural and synthetic polymers within the 
same electrospun mesh is blending both natural and synthetic polymers in a single solution 
to be electropsuned together, forming “poly-blended” nanofibers [3, 5].  
 
A broad variety of reports based on the combination of natural and synthetic polymers is 
available in literature. Yuan et al. fabricated wound dressing meshes by electrospinning a 
blend of modified keratin and poly (hydroxybutylate-co-hydroxyvalerate) (PHBV) [38]. 
Keratin is a fibrous proteins that performs an essential structural role in skin and hair. 
Wound healing and histological tests revealed that the composite membranes accelerated 
wound recovery   Kim et al. fabricated electrospun meshes by blending polyurethane (PU) 
and gelatin and showed their potential application in wound healing [39]. Gelatin is a 
natural polymer derived from collagen. It is widely used for biomedical purposes since it 
is biodegradable, non-toxic, and easily available at low cost. Another composite 
nanofibrous meshes, consisting of type I collagen, chitosan, and poly (ethylene oxide) 
(PEO), has been fabricated by Cheng et al [40]. The resulted membrane showed better 
wound healing rates than conventional dressing when used in rat models. Chitosan is a 
polysaccharide that can function as a proliferation promoter, antibacterial agent, and wound 
healing accelerator. 
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Owing to their well-known repetition as an effective wound healing agents, a lot of focus 
is now given to alternative natural compounds, including essential oils and honey. 
Generally, natural substances cannot be electrospun into fibers because of their week 
mechanical and structural stability upon hydration. In this regard, natural compounds are 
blended with synthetic polymers in order to be electrospinned. PVA/PAA/PEG/PVP 
nanofibers with HPMC and aloe Vera were fabricated by electrospinning method. HPMC 
was added to the hybrid polymer solution as the water retention agent and aloe vera were 
also added to the system to promote the wound healing. The fabricated nanofibers mats 
were homogenous and linear with nanofiber diameters ranged between 80-480 nm [41]. 
Also, honey is a very attractive natural material for wound healing purposes due to its anti-
inflammatory and antimicrobial properties. Sarhan, et al. were able to fabricate nanofibers 
with high honey concentrations (40%) and high chitosan concentrations (5.5%) of the total 
weight of the fibers using biocompatible solvents (1% acetic acid) [42]. The fabricated 
nanofibers showed pronounced antibacterial activity against Staphylococcus aureus but 
weak antibacterial activity against Escherichia coli. Also, the nanofibers revealed no 
cytotoxicity effects on cultured fibroblasts. Other natural products have been successfully 
electrospinned with natural and synthetic polymers. The data is summarized in Table 2.1.  
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Table 2.1: Some naturally derived substances used in interactive electrospun wound 
dressing 
Alternative
-naturally 
occurring 
materials 
Properties 
Scaffold 
material and 
solvent 
Electrospinning 
parameters 
Fiber 
Characterization 
Ref 
Emu-oil 
Facilitates 
wound healing 
and alleviates 
pain; analgesic, 
and anti-
inflammatory 
properties 
PU 
 
DMF/THF 
Voltage=16 KV 
Flow rate = NA 
Distance=15 cm 
Average 
diameters=400–
600 nm 
 
 
 
 
[43] 
Soya 
protein 
Promotes tissue 
regrowth, by 
integrating 
into blood clots 
and stimulating 
collagen 
deposition 
PEO 
 
HFP 
Voltage=12 kV; 
Flow rate= 0.8 
ml/h 
Distance=15 cm 
Average 
diameters=200–
1000 nm 
 
 
 
 
[44] 
Silk- 
fibroin 
Exhibits good 
oxygen and 
vapor 
permeability 
and minimal 
inflammatory 
reaction 
PEO 
 
Mixed with 
EGF 
Voltage=10–11 
KV; 
Flow rate= 1.2 
ml/h 
Distance= 15–
21 cm 
Fibers with 
flattened, ribbon-
like morphology 
Fibroblasts 
adhesion and 
proliferation 
within the fibers 
is shown 
Average fiber 
diameter=1000 
nm 
 
 
 
 
 
[45] 
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2.1.3 Advanced Interactive Electrospun Meshes 
Advanced interactive electrospun meshes are capable of delivering antibacterial agents to 
prevent and treat infection [3]. Number of researches are now focusing on preparing drug-
loaded nanofibrous meshes with controlled release property.  
 
Poly (ε-caprolactone) (PCL) electrospun fibers containing the antibiotic, ampicillin sodium 
salt, were successfully twisted into nanofiber yarns. A significant reduction in the diameter 
of fibers and diversity was observed with the addition of ampicillin salt to the polymer 
solution. The authors attributed such effect to the increase in conductivity of the polymer 
solution associated with the addition of the antibiotic salt. Also the antibacterial results 
indicated that the released antibiotic maintained its antibacterial activity after fabrication 
against both gram-positive Staphylococcus aureus and gram-negative Klebsiella 
pneumonia. Therefore the as-spun yarns were antimicrobial active [46]. In another study 
done by Qia at al. antibiotic drug tetracycline hydrochloride (TCH)-loaded halloysite 
nanotubes was incorporated in PLGA matrix to (TCH/HNTs/PLGA) prepare composite 
nanofibers [47]. The results showed that the incorporation of TCH-loaded HNTs within the 
PLGA nanofibers is able to improve the tensile strength and maintain the three-dimensional 
structure of the nanofibrous mats. Also, the cytotoxicity and cell attachment results 
demonstrated that the prepared composite is biocompatible with mouse fibroblast cells 
cultured onto the fibrous scaffolds. More importantly, the TCH/HNTs/PLGA composite 
nanofibers were able to release the antibacterial drug TCH in a sustained manner for 42 
days and display antimicrobial activity against S.aureus. The potential use of another class 
of antibiotic, ciprofloxacin, was also explored by Unnithan et al [48]. The authors were 
able to prepare antibacterial nanofibers membranes via electrospinning of solution 
containing dextron, polysaccharide molecule, polyurethane (PU) and ciprofloxacin HCl 
(CipHCl) drug. The obtained nanofibers mats had good morphology. The in vitro viability 
and SEM morphology observation indicated that the cells interacted favorably with the 
scaffolds especially the drug-containing one. Moreover, the results of the inhibition zone 
tests showed good bactericidal activity against both of Gram-positive and Gram-negative 
bacteria.  
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Another class of antibacterial agents that have been introduced in the advanced interactive 
electrospun meshes is the silver. Silver, either in its nanoparticle form (NPs) or as silver 
nitrate (AgNo3), has great bactericidal effect against wide range of bacterial. Duan et al. 
produced silver NPs-loaded antimicrobial nanofibers, intended as wound dressing, by 
electrospinning of a PCL solution with small amounts of silver-loaded zirconium 
phosphate nanoparticles (nano AgZr) [49]. The results of the antimicrobial tests showed 
that these fibers have maintained the strong killing abilities of Ag existed in the nano AgZr 
against the tested bacteria strains (Gram-positive) Staphylococcus aureus (ATCC 6538) 
and Gram-negative E. coli (ATCC). The cell proliferation results indicated that the human 
dermal fibroblast (HDF) cells were able to attach and proliferate as continuous layers on 
the nano AgZr-containing nanofibers and maintained the healthy morphology of HDF. 
Another technique for the preparation of silver NPs-loaded nanofibrous membrane was 
also investigated by Chen et al [50]. In this study, silver NPs-laoded nanofibers were 
prepared by electrospinning polyurethane (PU) solution containing silver ion, followed by 
UV treatment. The UV radiation reduce silver ion in the PU/AgNo3 nanofibers to silver 
nanoparticles. SEM, TEM and XRD analysis proved the presence of Ag NPs impeded 
within the nanofibers structure. For promoting wound healing, collagen was grafted to fiber 
surface by low temperature and oxygen plasma treatment. This can improve surface 
hydrophilicity of the membrane and facilitate covalent binding of collagen molecules to its 
surface. Results showed that inhibition of bacterial growth improved to approximately 
100%. This was also associated with the increase of membrane water absorption ability, 
which further facilitates its use as function wound dressing. Animal studies showed better 
healing performance for the prepared composite membrane in comparison to gauze and 
commercial collagen sponge..  
 
2.1.3.1 Plant extract and phytochemicals in advanced electrospun meshes 
Many medicinal plants have a long history of curative properties in wound healing. The 
capability of utilizing electrospinning technique to combine the advantages using these 
plant extracts in the form of nanofibrous mats and their potential application as skin graft 
substitutes has been investigated by number of researches. Four different plant extracts was 
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incorporated in PCL matrix and evaluated for their potential use in skin tissue engineering 
[51]. The plant species investigated in this study was Indigofera aspalathoides, 
Azadirachta indica, Memecylon edule (ME) and Myristica andamanica. The ability of 
human dermal fibroblasts (HDF) to proliferate on the electrospun nanofibrous scaffolds 
was evaluated via cell proliferation assay. The interaction of HDF with the electrospun 
scaffold was studied by F-actin and collagen staining studies. The results indicated that 
PCL/Me scaffolds possess the least cytotoxicity with HDF proliferation capacity 31% 
higher than the proliferation on PCL nanofibers after 9 days of cell culture. This percentage 
was the highest among all the other extract loaded-nanofibrous scaffolds. Therefore, the 
authors performed the epidermal differentiation of adipose derived stem cells on PCL/ME 
scaffolds and obtained early and intermediate stages of epidermal differentiation.  
 
In another study, the feasibility to utilize PCL, as a drug-delivery carrier for curcumin were 
investigated [52]. Curcumin is a phenolic phytochemical that is extracted from the roots of 
Curcuma longa L and is responsible for its medicinal properties. The high-specific surface 
area and high porosity can enhance the functional properties of Cur. Bead-free nanofibers 
were obtained by direct electrospinning of PCL/curcumin solution (7% curcumin based on 
the weight of polymer). The nanofibrous scaffolds showed a sustained release of curcumin 
for 72 h. The release profile also indicated that the drug can be deliver with a dose much 
lower than the reported cytotoxic concentration while remaining bioactive. The cell 
viability assays also indicated more than 70% viability for the Human foreskin fibroblast 
cells (HFF-1) on curcumin-loaded nanofibres. The curcumin-loaded nanofibres were able 
to reduce the inflammatory induction. This was proved by the low levels of interleukin-6 
released from mouse monocyte–macrophages seeded onto the scaffolds after being 
stimulated by E coli-derived lipopolysaccharide. The in vivo wound healing capability of 
the curcumin loaded PCL nanofibres was demonstrated by an increased rate of wound 
closure in a streptozotocin-induced diabetic mice model. These results demonstrate that the 
curcumin-loaded PCL nanofiber matrix is bioactive and has potential as a wound dressing 
with anti-oxidant and anti-inflammatory properties.  
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Crude bark extract of Tecomella undulate, a medicinal plant widely known for its 
traditional wound healing ability, were incorporated within PCL/PVP nanofibrous matrix 
[53]. Morphological characterization of the nanofibers by SEM showed that the 
incorporation of the herbal extract in the polymer media did not alter their morphology or 
size since both drug-loaded and drug-free nanofibers appeared to be smooth with the same 
diameter range. The composite saffolds showed high loading efficiency for the herbal 
extract. Also, the zone inhibition activity against standard strains of Pseudomonas 
aeruginosa MTCC 2297, Staphylococcus aureus ATCC933, Escherichia coli (IP-406006) 
showed that the prepared scaffolds were able to inhibit the growth of the all the tested 
bacterial strains. On the other hand, incorporating aqueous extract (5% Wt) of Grewia 
mollis Juss within (PU) nanofibers affected both the morphology and size of PU nanofibers 
[54]. FE-SEM-EDX and FT-IR results confirmed both well orientation of nanofibers and 
good dispersion of aqueous extract within the fibers. The antimicrobial effects of aqueous 
extract loaded fiber mats was studied against Escherichia coli ATCC 52922 (Gram 
negative) and Staphylococcus aureus ATCC 29231 (Gram positive) in liquid medium. The 
scaffolds were able to inhibit the growth of the bacterial strains.  
 
The capability of using PLA and CA as passive, interactive or advanced interactive 
electrospun meshes have been investigated through number of studies that will be 
discussed in the following sections. 
 
2.3 Cellulose acetate application in wound dressing 
The major component of fibrous extracellular matrix of dermis is composed of a complex 
combination of proteins and polysaccharides. Electrospuning of cellulose acetate, as a 
polysaccharide derivate, is considered an added value for tissue engineering purposes. 
Kontogiannopoulosa et al. investigated the probability of incorporating Alkannin and 
shikonin (A/S), naturally occurring hydroxynaphthoquinones in plants, within cellulose 
acetate electrospun fibers to be used for wound healing applications. Both drugs were 
effectively loaded into the nanofibrous mesh [55]. The incorporation of drugs did not 
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considerably affect fibers morphology and both drug free and drug loaded nanofibers were 
smooth with diameter varied from 315 to 670 nm. High drug entrapment efficiencies 
(ranged from 74% to 95%) and appropriate release profiles were achieved, that render these 
fibers as potential topical/transdermal wound healing dressings.  
 
Poly-blended NFs depending on cellulose acetate were also prepared and investigated for 
their potential use as topical/transdermal patches or as wound dressing [56]. In this study, 
a series of nanofibrous membranes were prepared from cellulose acetate (CA) and 
polyester urethane (PEU) blend-electrospinning. To prevent common clinical infections, 
an antimicrobial agent, polyhexamethylene biguanide (PHMB) was incorporated into the 
electrospun fibers. The presence of CA in the nanofibers membrane improved its 
hydrophilicity and permeability to air and moisture. CA-containing fibers showed better 
swelling behavior vapor permeability. In conclusion, inclusion of CA within the matrix not 
only increased the liquid uptake but also created a moist environment for the wound, which 
can further accelerate wound healing. The same conclusion, regarding improved 
hydrophilicity by incorporating CA, was also achieved by Unnithana, et al [57]. In this 
study, the author prepared an antibacterial CA-based nanofibrous scaffolds by 
electrospinng of solution of PU blended with CA and zein. PU was used as the foundation 
polymer while CA and zein was added to the matric to achieve desirable properties such 
as better hydrophilicity, excellent cell attachment, proliferation and blood clotting ability. 
An antibiotic, streptomycin sulfate, was incorporated into the electrospun fibers to prevent 
clinical infections. PU–CA–zein-drug composite nanoscaffold showed enhanced blood 
clotting ability in comparison with pristine PU nanofibers. The presence of CA and zein in 
the nanofiber membrane improved its hydrophilicity, bioactivity and created a moist 
environment for the wound. Also, the cell proliferation assessment revealed better cell 
growth and cell attachment on drug-loaded PU–CA and PU–CA–zein composite 
nanofibrous scaffolds than on PU nanofibers. 
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Vatankhah et al proved that combining both CA, as a polysaccharide derivative, and 
gelatin, as a protein, is an effective simulator of the structure and composition of native 
extracellular matrix (ECM) [58]. The authors successfully electrospun cellulose 
acetate/gelatin mats at different ratios and evaluated their performance as a scaffold for 
either skin tissue engineering or as a wound dressing. The results showed that the cell 
proliferation and adhesion capability is highly dependent on the composition of cellulose 
acetate and gelatin in the scaffolds. High proliferation of human dermal fibroblasts was 
obtained on electrospun cellulose acetate/gelatin 25:75. This confirmed the capability of 
such composite nanofibers as a tissue-engineered scaffold that can be used for full-
thickness wounds. On the other hand, electrospun cellulose acetate/gelatin 75:25 can be a 
potential low-adherent wound dressing, which can be easily removed. Thus, it can be 
applied for superficial wounds. 
 
2.4 Poly-lactic acid application in wound dressing 
Poly (L-lactic acid) (PLLA) is a biocompatible synthetic polymer which was approved by 
the Food and Drug Administration for specific human clinical applications, and had 
eximious mechanical property. Its electrospinning product was increasingly used as an 
effective drug-delivery carriers [59]. PLA has been electrospun by Alsi et al. to act as a 
carrier matrix for controlled delivery of highly porous silver microparticles [60]. The 
author found that the highly porous silver microparticles (AgMPs) could be successfully 
incorporated in nanofibrous and that the PLA porous AgMPs-loaded nanofibers showed a 
steady silver ion release at a greater rate than that of AgNPs-loaded nanofibers. Also, the 
AgMPs-loaded nanofibers matrix exhibited comparable antimicrobial efficacy and 
cytotoxicity to the AgNPs- loaded nanofibers matrix.  
 
In another study that utilized PLA as a carrier matrix, a crude extract of Garcinia cowa 
Roxb. (GC) were used as the bioactive drug. The fibers of both the neat and the GC-loaded 
PLLA fibers (up to 50% extract based on the weight of the polymer) were smooth, with 
average diameters of 0.80–1.13 μm [61]. The results showed that the release profile of the 
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GC extract depends on the release media used and temperature. The maximum cumulative 
amount of extract released from the GC-loaded PLLA fiber mats in the phosphate buffer 
medium (at 37 °C) was greater than that released in the acetate buffer medium (32 °C). The 
1, 1- diphenyl-2-picrylhydrazyl (DPPH) assay, used to assess the antioxidant activity, 
showed that the GC-loaded PLLA fiber mats maintained its antioxidant potential even after 
being exposed to a high electrical potential like that applied during electropinning. Also, 
the prepared matrix showed antimicrobial effect against Straphylococcus aureus ATCC 
25923 and Straphylococcus aureus DMST 20654. Lastly, almost all of the GC-loaded 
PLLA fiber mats were found to be nontoxic to normal human dermal fibroblasts except for 
those that contained 50 % extract. 
 
In spite of the biocompatibility of PLA, further application of PLA fiber in biomedical 
materials is hindered by its hydrophobicity. Consequently, there is an attempt to increase 
the hydrophylicity of PLA to be applicable in wide range of tissue engineering applications 
including wound dressing. In this regard, number of modification techniques have been 
investigated including: copolymerization of lactide with other monomers or polymers such 
as malic acid, polyethylene glycol (PEG), polyglycolic acid (PGA), or dextran, as well as 
surface modification such as plasma treatment and surface coating [24,62-64]. However, 
blending polylactide with other polymers is a simple yet attractive method for 
modification[63]. Polymer blending can combine and optimize the polymeric physical 
properties of interest. One advantage of using polymer blends over the synthesis of new 
polymers is that the composition of the polymer blend is controlled easily and is subject to 
change according to applications requirements. Polymer blends can also provide effective 
control on the release profile for pharmaceuticals [64]. Thus, it can offer significant 
advantages over traditional drug delivery techniques. Optimizing and fine-tuning of the 
bio-functionality of PLA electrospun nanofibers through blending method was 
demonstrated in number of studies .Polyvinylpyrrolidone (PVP) is also a biocompatible 
synthetic polymer, and is a hydrophilic in nature. So, PVP is a good material to prepare 
composite material with PLLA for improving the hydrophilicity of obtained hybrid matrix. 
Xu, et al conducted a study to introduce PVP into PLLA nanofibrous structure. Different 
ratios by weight (PVP/PLLA: 1/1, 1/3, and 1/9) were prepared using trichloromethane as 
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solvent [65]. The water contact angle assay, used to test the degree of hydrophilicity of a 
membrane, indicated that the higher is the PVP ratios, the higher is the hydrophylicity of 
the matrix. Thus, the hydrophilicity of nanofiber matrix could be adjusted by controlling 
the content of PVP. The authors assumed that that the prepared spun ultrafine fibers can be 
used as a synthetic extracellular matrix scaffold for tissue engineering. 
 
Another issue which limit the application of PLA in tissue engineering and wound dressing 
purposes is the poor cell affinity and lack of cellular interaction, thus they do not favor 
cellular adhesion and migration [62, 63, 66]. To enhance cell adherence on scaffold and 
improve cellular response, the surface of PLA nanofibrous scaffold was modified by 
gelatin. Gelatin, as explained before, is the widely used natural polymer for its low cost 
and high cellular response [63]. For electrospinning, PLA and gelatin were dissolved in 
hexafluoroisopropanol (HFIP) solvent at varying compositions (PLA: gelatin at 3:7 and 
7:3). Cellular viability and proliferation results showed that the modified PLA/gelatin 7/3 
scaffold is more suitable for fibroblasts attachment and viability than the PLA or gelatin 
nanofiber alone. Thus fibroblast cultured on PLA/gelatin scaffold could be an alternative 
way to improve skin wound healing. In another study, the incorporation of collagen type I 
within the PLLA electrospun nanofibers can effectively modulate certain aspects of cellular 
behavior even at very minor concentrations (<1% w) [66]. Such aspects includes cellular 
attachment. The study showed that cell attachment after 24 h were significantly higher on 
collagen/PLLA scaffolds when compared to pure PLA scaffolds. Also, the results showed 
a clear differences in cell penetration. Cells migrated through 32 and 85% of PLLA and 
collagen/ PLLA scaffolds after one week, respectively. Finally, mineralization of primary 
calvaria osteoblasts provided further evidence that collagen- containing electrospun PLLA 
scaffolds could sustain cell differentiation.  
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2.5 Thymoquinone: Medicinal properties and 
applications 
Thymoquinone (TQ) has been investigated for their antibacterial properties. In a study that 
was conducted by Halawani, the bactericidal potential of thymoquinone (TQ) and its 
derivative, thymohydroquinone (THQ) [35]. The two main ingredients in Nigella sativa, 
were investigated against 6 bacterial strains: Escherichia coli, Pseudomonas aeruginosa, 
Shigella flexneri, Salmonella Typhimurium, Salmonella Enteritidis and Staphylococcus 
aureus. Both TQ and THQ exerted antibacterial activity against all the tested bacterial 
strains. Gram-positive bacteria were more susceptible to both TQ and THQ than the gram-
negative bacteria, with miniumn inhibitory concentration (MIC) ranged between 200 and 
1600 μg/ml. Among all the tested bacterial strains, S. aureus showed to be highly 
susceptible to TQ than THQ. The MIC of TQ that is required to inhibit the growth of S. 
aureus was 3-6 μg/ml while that required in case of THQ was 400-800 μg/ml (100 times 
higher). Also the combination of TQ and THQ with antibiotics (ampicillin, cephalexin, 
chloramphenicol, tetracycline, gentamicin, and ciprofloxacin) exerted synergism in only in 
case of S. aureus. While for gram-negative bacteria, synergism, antagonism and indifferent 
effects were detected. This study demonstrated that TQ is more effective than THQ 
regarding its antibacterial effect, and that their activity could be potentiated by antibiotics 
especially in case of S. aureus. On the other hand, Hossain et al.  presented that the 
minimum bactericidal and inhibitory concentration of TQ to Staphylococcus aureus was 
31μg/mL(188.8 μM) [34] . Also, the authors presented that the the minimum inhibitory 
concentration of TQ for Bacillus anthracis was 3 μg/mL (18.3 μM).   
TQ not only used as antibacterial agent but it can be also used as an anti-biofilm agent, 
inhibit the formation of bacterial bio-films on surfaces. The antibacterial activity of (TQ) 
and its biofilm inhibition potencies were investigated on 11 human pathogenic bacteria 
[67]. The development of the bacterial biofilm were evaluated using the crystal violet (CV). 
The results showed that TQ exhibited a significant antibacterial activity against the 
majority of the tested bacteria (MICs values ranged from 8 to 32 μg/ml) especially Gram 
positive cocci (Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis CIP 
106510). This results actually correlate with the results obtained by other authors as 
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discussed before. Crystal violet assay showed that the minimum biofilm inhibition 
concentration (BIC50) was reached with 22 and 60 μg/ml for Staphylococcus aureus 
ATCC 25923 and Staphylococcus epidermidis CIP 106510 respectively. In addition, TQ 
prevented cell adhesion to glass slides surface, thus it prevent biofilm formation. 
Consequently, TQ can be used as bioactive substance with anti-biofilm potential. All this 
studies done on TQ proves that such phytochemical deserves further exploration as an 
effective alternative to customary medicines for pathogenic bacteria. 
Because of the anti-bacterial, anti-inflammatory and antioxidant activities of TQ, Selcuk, 
et al hypothesized that TQ would reduce inflammation and oxidative stress and accelerate 
wound closure in a rat model of deep second-degree burns. The results proved that tropical 
and/or systemic administration of TQ reduced inflammation and oxidative stress and 
accelerated the rate of wound closure or re-epithelialization. 
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3 Materials and Methods 
 
3.1 Materials 
Poly (lactic acid) (PLA) pellets with a commercial name “Ingeo” grade 4043D were 
purchased from NatureWorks LLC, Minnetonka, USA. The purchased grade has a relative 
solution viscosity (RV) of 4.0 ± 0.10, and a level of D-isomer of 4.25 ± 0.55%. Cellulose 
acetate was purchased from Loba Chemie, Mumbai, India. The cellulose acetate has degree 
of acetylation~ 24%. Criterion TM nutrient broth (500 g), and Criterion TM nutrient agar 
(500 g) were purchased from Hardy Diagnostic, Thymoquinone (extra-pure), 
Dichloromethane (DCM) (≤99%), N,N dimethyl-formamide (≤99%), absolute ethanol 
anhydrous, sodium phosphate dibasic (extra-pure MW=141.96), sodium phosphate 
monobasic dehydrate (extra-pure, MW=156.01 ), sodium hydroxide (extra-pure), Sodium 
dodecyl sulfate (extra-pure, MW= 288.38), Dulbecco’s modified eagle’s medium, MTT 
cell proliferation kit, and glutaraldehyde solution (25%) were purchased from Sigma 
Aldrich, Germany. All chemicals were used directly without further purification.  
 
3.2 Experimental Procedures 
 
3.2.1 Preparation of polymer solutions 
Polymer solutions were prepared in DCM: DMF (7:3 V/V) at concentration of 6% w ratio. 
PLA: CA solutions were prepared in two different weight ratios including, 9:1 and 7:3 (% 
w) to get polymer solution of final concentration 6% w. To prepare the drug-loaded 
samples, 3% w TQ (concentration based on the weight of the polymers) was added for each 
polymer solution. Two other drug concentration ratios have been also prepared (1 and 5 % 
w) within the PLA NFs, to get the optimum morphology and biological activity. All the 
prepared samples were stirred vigorously for 4-6 h until a homogenous solution was 
obtained. TQ is known to be a light sensitive drug, thus all samples were covered with 
aluminum foil sheet and maintained at room temperature until electrospinning.  
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3.2.2 Electrospinning 
After stirring for 4-6 h, each polymer solution was loaded into a 5-ml syringe attached to a 
27G blunted stainless steel needle at a flow rate of 1.5 -3 ml/h. A high voltage of 20-24 kV 
was applied to the tip of the needle. The fibers were deposited on a flat aluminum foil that 
is wrapped around a stationary collector. The distance between needle tip and the stationary 
collector was kept at 15 cm throughout the process. The electrospinning conditions for each 
polymeric solution has been adjusted, depending on trial and error, until the optimum 
electrospinning solutions are obtained (Table 3.1). This is reflected in the morphology of 
the fibers, examined by the SEM. All the electrospinning processes were carried out at 
approximately 28 ᵒC and 30 % humidity. Nanofibrous membranes were dried in a vacuum 
oven for 24 h to ensure the complete vaporization of all solvent residuals.  
 
Table 3.1: Electrospinning parameters used for fabricating TQ-loaded PLA, TQ-loaded PLA: 
CA 9:1 and TQ-loaded PLA: CA 7:3. 
Polymer 
solution 
ratio 
Voltage 
(KV) 
Needle tip-
collector 
distance (cm) 
Nozzle Flow rate 
(ml/h) 
Concentration 
(% w) 
PLA CA 20 15 25 3 6 
10 0 
PLA CA 22 15 25 2.5 6 
9 1 
PLA CA 24.5 15 25 1.5 6 
7 3 
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3.3 Characterization of Polymeric solution 
 
3.3.1 Viscosity measurements 
The viscosity of the polymeric solutions has been determined using the viscometer (VR 
3000 model: L. Viscotech Hispania S.L., Spain). All measurements were carried out at 
room temperature 25 ο C, 200 RPM and the probe used is L2 
3.4 Characterization of the prepared electrospun 
nanofibers 
 
3.4.1 Scanning electron microscopy  
The morphology of the prepared e-spun nanofibers were observed under scanning electron 
microscopy (SEM: FEI-QUANTA 200F, Netherland) at an accelerating voltage of 15 kV. 
Before SEM observations, the samples were sputter-coated with gold films of a thickness 
10 nm. (JEOL JFC-1600 Auto fine coater, Japan). The samples were gold-sputtered to 
obtain images of better quality through charge dissipation. SEM images were analyzed 
with image analysis software (Image J, National Institutes of Health, USA) to determine 
average fiber diameter. A total of 50 random NFs per image were used to calculate the 
mean and standard deviation of fiber diameter. 
 
3.4.2 Fourier transform infrared spectroscopy 
The chemical composition of the prepared samples was studied by Fourier transform 
infrared spectroscopy, using a Spectrum PerkinElmer (Wiesbaden, Germany). The infrared 
spectra of the drug –free PLA: CA 7:3, TQ-loaded PLA: CA 7:3 and TQ-loaded PLA e-
spun nanofibers matrices were measured over a wavelength range of 4,000–550 cm−1 at a 
resolution of 4 cm-1. 
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3.4.3 Porosimetry  
Pore diameter distribution, pore surface area distribution, and the porosity of the 
electrospun TQ-loaded PLA, TQ-loaded PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 were 
measured using a mercury intrusion porosimeter (Poresizer Quantachrome Instruments, 
Florida, USA) in mercury intrusion under an increasing pressure from 100 kPa to 207MPa, 
which was carried out at the YJSTRC Research Center (AUC). The determination of 
porosity was based on the relationship between the applied pressure and the pore diameter 
into which mercury intrudes, according to the Washburn equation: 
 
𝐷 = (−4𝛾𝐶𝑂𝑆𝜃)/𝑃                        (1) 
 
Where P is the applied pressure, D is the pore diameter, γ is the surface tension of the 
mercury (484mNm-1 ) and 𝜃 is the contact angle between mercury and the pore wall, taken 
as 141.31ᵒC. 
 
3.4.4 Swelling behavior and water retention capacity 
The water retention and swelling behaviors of the medicated NFs scaffolds were measured 
in a phosphate buffer solution at the physiological temperature (37 °C) for 12, 24 and 48 h 
with four replicas. After immersion, fibrous mats were weighted after wiping the excess 
solution adhered on the ultrafine mat with filter paper. The percentage swelling or the 
water-up take capacity of the nanofibers was calculated using the following equation: 
 
𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔 (% 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑢𝑝 𝑡𝑎𝑘𝑒) =  
𝑊𝑡 − 𝑊𝑑
𝑊𝑑
 × 100      (2) 
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Where Wd is the weight of each sample before submersion in the buffer solution and Wt is 
the weight of the sample after submersion for a certain time interval (t). Each sample was 
investigated in triplicates and the data was expressed as ± mean standard deviation. 
3.4.5 Water vapor permeability  
The water vapor permeability of the developed medicated scaffolds was determined 
through the evaluation of the water vapor transmission rate (WVTR) through the 
membranes. The test was carried out by the ASTM standard E 96 method [68]. The 
scaffolds were cut into circular discs with a 4.5 cm diameter and a 0.25± 0.05 mm 
thickness. Then, scaffolds were mounted onto the mouth of autoclave bottles (100 ml). The 
bottle was filled with pre-dried desiccant (calcium chloride). The desiccant was first dried 
in a vacuum oven for 24 h at 40 
ᵒ
C. About one-quarter of the total volume of each bottle 
was filled. The scaffolds were tightly fixed using paraffin tape along the edges of the bottle 
to prevent water vapor entrance across the periphery. The whole setup was maintained at 
ambient temperature with a 75% constant relative humidity in a dry cabinet (Digi-Cabi, 
AD-200) to ensure accurate control of humidity. The humidity was kept constant 
throughout the time of the experiment with the aid of saturated sodium chloride solution. 
At regular intervals, the samples were weighed, and the weight gain was determined. A 
graph was plotted for the weight gain versus time and from the graph slope, we calculated 
WVTR (g/m2/day) from the following equation: 
𝑊𝑉𝑇𝑅 =  
𝑆𝑙𝑜𝑝𝑒
 𝐴
                 (3) 
 
Where A is the exposure area of the scaffolds (m2). Four sets of samples were examined to 
obtain the replicable results. 
 
3.5 In Vitro drug release study 
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3.5.1 Calculation of Total TQ content in TQ-loaded nanofibers 
Prior to investigating the release profile of TQ from the prepared e-spin nanofibers, the 
actual content of drug was first calculated. This represents the amount of drug incorporated 
within the nanofibers, inside it or on the surface, compared to the initial amount of drug 
used in the solution. A pre-weighted mount of each sample (circular disc of 3-5 mg) was 
dissolved in 5 ml of 7:3 V/V DCM: DMF. The samples were dissolved under vortexing in 
order to destroy the fibrous structure, thus releasing the drug in the organic phase. After 
that, the Absorbance of TQ in the organic phase was determined by UV/VIS 
spectrophotometry (Cary 60 UV-VIS/Agilent technologies) at the characteristic 
wavelength for TQ (255 nm). The actual amount of TQ in the e-spun fibers was then back 
calculated from the obtained data against a predetermined calibration curve for TQ. Such 
linear calibration curve was obtained by measuring the absorption of different TQ solutions 
of known concentrations (see appendix). The obtained relationship is shown in the 
following equation: 
 
Drug concentration (𝜇g/ml) = 9.587× Absorption (R2=0.9984) 
The total drug content (entrapment efficiency) was then calculated using the following 
equation: 
𝑇𝑜𝑡𝑎𝑙 𝑑𝑟𝑢𝑔 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 = (
𝑋𝑖
𝑋𝑓
) × 100           (4) 
 
Where Xi is the amount of drug successfully incorporated into the nanofibers and Xf   is the 
initial amount of drug added in the electrospun solution.  In order to examine the uniformity 
of drug distribution throughout the fibrous mats, the total drug content from random parts 
of the fibrous construct was determined as described above. Three replicate mats were 
analyzed each time. The average of the obtained values was used as the basis to determine 
the cumulative release of TQ from the TQ-loaded e-spun mats. 
 40 | P a g e  
 
 
 
3.5.2 Release of TQ from TQ-loaded nanofibers 
 
3.5.2.1 Preparation of release medium 
For the intended application of the TQ-loaded nanofibers as wound dressing materials, 
phosphate buffer solution of the physiological pH (pH=7.4) was used as the release 
medium. 1000 ml of phosphate buffer was prepared by dissolving 6.177 g of anhydrous 
disodium hydrogen orthophosphate and 1.014 g of sodium dihydrogen orthophosphate in 
100 ml distilled water. Then, 8.7 g of sodium chloride were added to the solution. Finally, 
distilled water was added to obtain the required volume. The pH was then adjusted to 7.4 
by addition of few drops of 2 N sodium hydroxide. Due to the poor solubility of TQ in 
aqueous solutions, modification of the release media was necessary. In this regards, 1% 
w/v of sodium dodecyl sulfate (SDS) and 10% v/v of ethanol were added to the media to 
facilitate the dissolution of TQ in aqueous media.  
Addition of emulsifiers and alcohols, as dissolution aids in aqueous media, for 
investigating the release of hydrophobic drugs is very common. Taepaiboon et al and 
Suwantong et al used methanol-containing acetate buffer as the release medium to study 
the release profile of Vitamin E and curcumin from Vit E-loaded and curcumin-loaded 
cellulose acetate nanofiber, respectively [69]. On the other hand, Konstantinos et al used 
1% SLS within the acetate buffer solution to study the release of shikonin from CA 
nanofibers [55] . Again, Suwantong used both 0.5% v/v tween 80 and 3% v/v methanol to 
facilitate the dissolution of Garcinia cowa extract, loaded on PLLA nanofibers, into acetate 
buffer release medium [61].  
 
3.5.2.2 Thymoquinone release assay 
The total immersion method was used to investigate the release characteristics of TQ from 
the medicated nanofibers TQ-loaded neat PLA, TQ-loaded PLA: CA 9:1 and TQ-loaded 
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PLA: CA 7:3. Since TQ is a hydrophobic drug that is readily insoluble in water, the release 
study was carried out under the sink conditions i.e. the drug concentration was kept below 
its solubility limit. The drug release experiment was carried out by incubating the samples 
in the aforementioned release medium. 30-35 mg of each sample were added in separate 
vials with 5 ml release medium. Samples were incubated at the physiological temperature, 
37 ᵒC. At specific immersion times, ranging from 1 h to 9 days, the 5 ml release medium 
were withdrawn from the vials and replaced with equal amount of fresh medium.  
The amount of TQ released at the different time intervals was determined using UV-vis 
spectrophotometer at 255 nm, with the aid of the following calibration curve of the TQ in 
the same release medium: 
Drug concentration (𝜇𝑔/𝑚𝑙) = 9.023× Absorption (R2=0.9991) 
The cumulative percentage of the drug released was calculated using the equation below 
and then plotted versus time. 
 
 % 𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 𝑑𝑟𝑢𝑔 𝑟𝑒𝑙𝑒𝑎𝑠𝑒 = (
𝐷𝑟𝑢𝑔 𝑟𝑒𝑙𝑒𝑎𝑠𝑒𝑑 𝑎𝑡 𝑡𝑖𝑚𝑒 (𝑡)
𝑡𝑜𝑡𝑎𝑙 𝑒𝑛𝑡𝑟𝑎𝑝𝑝𝑒𝑑 𝑑𝑟𝑢𝑔 
) × 100           (5) 
 
3.6 In vitro antibacterial assessment  
 
3.6.1 Microbial strains and culturing conditions 
The following micro-organisms were used for antibacterial assessment study: Escherichia 
coli and Staphylococcus aureus ATCC25923. The bacterial strains were supplied by the 
VACSERA center. Preparation of bacterial inoculum occurs as follows: the gram-negative 
E. coli, and gram-positive bacteria S. aureus were pre-cultured in Criterion TM nutrient 
broth (NB) overnight in a rotary shaker at 37
◦
C, centrifuged at 13,000 rpm for 2 min, then 
pellet was suspended in sterile water and the cell density was standardized 
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spectrophotometrically (Absorbance: 570 nm) to be 108cells/ml. A melted agar/bacterial 
suspension is then prepared by the agar overlay technique. Briefly, 100 ul of diluted 
bacterial suspension was added to a soft top agar (0.75%, as opposed to the usual 1.5% for 
agar plates) which has been melted at 100°C and cooled to 45°C. This is warm enough so 
the agar remains liquid, but cool enough so that the bacteria are not killed. Suspension of 
microorganisms in the agar melt is mixed and then spread evenly as a thin layer across the 
top of Petri dishes. The melted agar/bacterial suspension is then allowed to solidify. The 
Criterion TM Mueller– Hinton (MH) nutrient agar was used for both S. aureus and for E. 
coli.  
 
3.6.2 Antibacterial activity measurement 
The antibacterial efficiency of the medicated samples, containing TQ, was tested by the 
disk diffusion method or the Modified Kirby-Bauer antibiotic test [70]. The nanofiberous 
mats, TQ-loaded PLA: CA 7:3, TQ-loaded PLA: CA 9:1 and TQ-loaded PLA, were cut 
into circular discs of diameter around 1.5 cm each and denoted as A, B and C, respectively. 
The discs were first sterilized under UV light for 2 h then placed on the top of the smeared 
agar plates. The antibacterial activity plates were placed in the refrigerator for 8 h to allow 
for the release of the drug. Then, the plates were incubated at 37◦C for 24 h. Upon reaching 
the inhibitory concentration, microbial growth stops, which can be seen as a clear inhibition 
zones around the disc samples. The diameters of the inhibition zones were measured with 
transparent ruler. The experiments were performed in triplicate. All results were expressed 
as the mean ± standard deviation of the mean. The antibacterial plates were photographed 
for further evaluation.  
 
3.7 Cytotoxicity, Cell proliferation and cell attachment 
assessment: 
 
3.7.1 Cell line and maintenance  
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Cell culture studies were carried out using mouse fibroblast cells (3T3-L1). The 3T3-L1 
fibroblasts (VACSERA center, Cairo) were initially maintained in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum, 1% glutamine, 100 μg/ml 
penicillin, and 100 μg/ml streptomycin. The medium was replaced every 3 days and 
cultures were maintained in an incubator with 5% CO2 at 37
◦
C. (incubator, ASTEC, Japan). 
The cells were sub-cultured in a 25 cm2 tissue culture flasks with modified DMEM. The 
fibroblasts were grown to confluency. Before each assay, confuent cells were detached by 
adding 1ml of 0.25% of trypsin containing 0.1% EDTA. Detached cells were centrifuged 
at 1500 r/min for 5 min, counted by trypan blue using a hemocytometer and seeded on the 
desired substrate (prepared nanofibrous scaffolds or the tissue culture polystyrene plate 
(TCP) as control ) at a certain cell density (mentioned below). 
The electrospun nanofibrous mats were cut into circular discs of diameter 1.5 cm. The 
scaffolds were first sterilized by being exposed to UV radiation for 1 h, before using in any 
cell culture assay. Each sample underwent each treatment in triplicate. The results were 
expressed as the mean ± standard error of the mean. 
 
3.7.2 Cytotoxicity assay 
In this study, the release of TQ from TQ-loaded nanofibers in a cell culture medium was 
investigated in order to test the effect of TQ concentration on cell growth. The indirect 
cytotoxicity evaluations of the medicated NFs mats were carried out by the ISO10993-5 
standard test method as a reference [71]. ISO 10993–5 specifies the incubation procedure 
of cultured cells in contact with a device or with extracts of a device either directly or 
through diffusion. Briefly, the assay was performed in a 96-well tissue culture polystyrene 
plate (TCPS; Costar®, Corning, NY, USA) using mouse fibroblast. The UV-sterilized 
circular discs (1.5 cm) were immersed in serum-free medium (SFM), containing DMEM, 
1 % L-glutamine, and 1 % antibiotic and antimycotic formulation for 24 h of incubation to 
produce extraction media at various extraction ratios (i.e., 100, 50, 25, 12.5 and 0 %). The 
extraction media was then filtered using a 0.20 μm filter (DISMICR -25AS). Fibroblast 
cells were separately cultured in 96 well cell culture plate of at 104 cells/well in serum-
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containing DMEM for 24 h. After that, the medium was replaced with the extraction 
medium (100μl) of every fibrous scaffold, and the cells were re-incubated for 24 h. The 
viability of the cells cultured by each extraction medium was finally determined using a 3-
(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay according to 
the manufacturer’s instructions. 
 
The MTT assay is based on the reduction of the yellow tetrazolium salt to purple formazan 
crystals by the action of dehydrogenase enzymes, secreted from the mitochondria of 
metabolically active cells [58]. The amount of purple formazan crystals formed is 
proportional to the number of viable cells. After the 24 h incubation, the extraction medium 
in each plate was aspirated and replaced with 25 μl/well of MTT solution (5 mg/ml in PBS). 
The plate was incubated at 37 
ᵒ
C for 4 hours, the medium was then aspirated and 150μl/well 
of DMSO was added to dissolve the formazan crystals. The optical absorbance was 
measured at 595 nm using an ELISA reader (Turner Biosystems CE, Promega Corporation, 
USA). The viability of the cells cultured with the fresh SFM was used as a control. Cell 
viability (%) was calculated based on the following equation: 
𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑟𝑎𝑡𝑒 % =
𝐴 𝑠𝑎𝑚𝑝𝑙𝑒 − 𝐴 𝐵𝑙𝑎𝑛𝑘  
𝐴 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝐴 𝑏𝑙𝑎𝑛𝑘
 × 100           (6) 
 
 
3.7.3 Cell proliferation and cell growth viability 
3T3-L1 fibroblast were cultured on medicated e-spun membranes to evaluate the direct 
biocompatibility of the wound dressing scaffold, and the results were compared to cell 
cultures on tissue culture polystyrene as the control (TCPS). The proliferation of cultured 
fibroblasts was monitored on the first, third and seventh day of culture using the 
colorimetric MTT assay and the viable cell count technique.  
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3.7.3.1 MTT assay 
In the MTT cell proliferation assay, the control (tissue culture polystyrene only), the TQ-
loaded PLA, TQ-loaded PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 scaffolds (circular disc 
1cm in diameter) were placed inside the 24-well plate. The pre-sterilized electrospun 
scaffolds were first rinsed twice with phosphate-buffered saline (PBS) and soaked in cell 
culture medium overnight prior to cell seeding to facilitate protein adsorption and cell 
attachment. Mouse fibroblast cells were grown to confluency and then the cells were 
detached by adding 1 ml of 0.25% trypsin containing 0.1% EDTA. The pre-prepared cells 
were seeded on the scaffolds at a cell density of approximately 2×10
4
 cells/well and 
incubated at conditions suitable for cell growth. The scaffolds were transferred to a new 
plate (24 well-plate) after incubation and rinsed with PBS for twice. Then, 200μl of the 
MTT solution was added to the scaffolds and incubated at 37 
ᵒ
C for 4 h. The scaffolds 
containing MTT-cell mixtures were gently rocked to deposit the cells. After incubation, 
the supernatant MTT solution was discarded and 1ml of DMSO was added to the colored 
cell deposit to dissolve the formazan crystals. Then, 150 μl of the purple-blue solution 
containing the solubilized formazan in each sample, was transferred to a 96-well plate. 
Again, optical absorbance was measured at 595 nm using an ELISA reader. The cell 
viability was obtained by comparing the absorbance of cells cultured on the nanofibers 
scaffold to that of control well containing cells.  
 
3.7.3.2 Determination of viable cell suspension concentration 
Cell viability and proliferation were also assessed using the viable cell count technique, 
using haemocytometer. The fibroblast cells were cultured on each scaffold for 1, 3 and 7 
days as previously mentioned. The cell monolayer was trypsinized using 1 ml of Trypsin / 
EDTA solution (0.25%) for the detachment of cells. The detached cells were then re-
suspended in appropriate amount of fresh medium containing 10% fetal bovine serum. 100 
µl of cell suspension was taken and mixed with an equal volume of trypan blue and mixed 
by gentle pipetting (dilution factor = 2). The haemocytometer and cover slip was cleaned 
with 70% ethanol then the cover slip was slide over the chambers. Both sides of the 
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chamber were filled with 10 µl of cell suspension and the cell viability was examined under 
the inverted microscope. The bright non-stained cells (viable cells) and stained (non-viable 
cells) were counted and viable cell concentration were determined using the following 
equation: 
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠(𝑐𝑒𝑙𝑙𝑠 𝑚𝑙⁄ ) = 𝐴 × 𝐶 × 𝐷             (7) 
 
Where: A: The mean number of viable cell counted; C: The correction factor (this is 
provided by the haemocytometer manufacturer) and D: The dilution factor 
 
3.7.4 Cell attachment assay 
In order to evaluate the cell adhesion capacity and attachment manner on the composite 
scaffolds, chemical fixation of cells on each scaffolds was carried out. Briefly, the samples 
were harvested after 3 and 5 days of culturing, rinsed twice with PBS to remove non-
adherent cells, fixed with 2.5% glutaraldehyde for 1 h and washed with PBS twice (15 min 
per time). The samples were then dehydrated using a series of ethanol solutions, 20, 30, 
50, 70 and 100% ethanol for 10 min each. Finally, the samples were kept in a vacuum oven 
and then sputter coated with gold for the cell morphology observation by using SEM. All 
samples were air-dried overnight. The dried cells were sputtered with a 10 nm thick gold 
film for the cell morphology observation using the MED020 instrument (Bal-Tech system, 
USA). Cell attachment was then observed at each time point using SEM (JEOL JSM-
5600LV) with an accelerating voltage of 10 kV. 
 
3.8 Wound healing assay 
Six C57BL/6 mice (14–16 g) were used in this study, divided into two groups (1 and 2). 
The mice were housed under standard conditions with controlled temperature (23 ᴼ C) 
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and a light/dark cycle (12/12 h). After anesthetization, the dorsal hairs of the mice were 
completely shaved. To create a wound on each animal, a biopsy puncher was used to 
create a wound along the dorsal side of the skin. Two circular wounds with a surface area 
of 1 cm2 were created on the back of each mice, one wound is treated with the NFs 
scaffold, while the second wound is treated with gauze, as control. In this assay, 
medicated PLA: CA (7:3) and medicated PLA scaffolds were used. The wound areas 
were sterilized with povidone iodide. After 1 day, the dead skin around the wound was 
excised to the full thickness with scissors and tweezers. For Group 1 mice represent 
wounds treated with TQ-loaded PLA: CA (7:3) scaffolds vs. control. On the other hand, 
Group 2 mice were treated with TQ-loaded PLA scaffolds vs. control. The changes in the 
wound areas were measured at 0, 7, 10 and 14 days after initial wounding. The 
percentage healing is defined by equation (8): 
 
𝑊𝑜𝑢𝑛𝑑 𝐶𝑙𝑜𝑠𝑢𝑟𝑒 𝑟𝑎𝑡𝑒 (%) = [𝐼𝐴 − 𝑀𝐴 𝐼𝐴⁄ ] × 100               (8) 
 
In which IA is the initial wound area and MA is the measured area after certain time 
period of treatment.  
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4 Results and Discussion 
4.1 Viscosity measurements  
The viscosity of the prepared polymer solutions are presented in table 4.1. It is clear that 
PLA: CA polymer solutions showed much lower viscosity compared the PLA solutions. 
The reason for decreasing solution viscosity, associated with CA incorporation, may be 
attributed to the interaction between the CA and PLA polymer chains. The CA polymer 
chain may also have interfered with the secondary interaction, occurring between PLA 
chains. Thus reducing the viscosity of the solution. 
4.2 Morphological characterization 
SEM micrographs of the drug free PLA, PLA: CA 9:1 and PLA: CA 7:3 NFs are presented 
in Figure 4.1. Figure 4.2 shows the morphology of the drug-loaded PLA, PLA: CA 9:1 and 
PLA: CA 7:3 NFs at drug ratio 3 % w.  SEM micrographs of the drug-loaded PLA NFs at 
the drug ratio 1 and 5 % w are represented in the appendix. 
The results shows that under the optimized spinning conditions, the fibers obtained were 
randomly oriented round-shaped with smooth surface and almost uniform diameters along 
their lengths. Thus, one can claim that the obtained randomly oriented nanofibers are 
beads-free. The diameter of electrospun drug-free PLA: CA 7:3 and PLA: CA 9:1 was 
significantly lower compared to that of drug-free PLA nanofibers (Table 4.1). These results 
indicate that blending CA with PLA has resulted in shifting the fiber diameter to the lower 
values. This can be attributed to the decrease in solution viscosity associated with the 
incorporation of CA in the prepared polymer solution.  
Solution viscosity influences the morphological structure and average size of the resulting 
fibers. By increasing the viscosity, the diameter of the NFs increases. This is probably 
attributed to the higher polymeric chain entanglement. During electrospinning, such chain 
entanglement results in greater resistance to the stretching of the polymer jet by the effect 
of electrostatic repulsive force [22, 72] In a study done by Bai et al to determine the effect 
of solution viscosity on the diameter of polymeric nanofibers, phenolic-resin solution was 
investigated [72].  The viscosity of the prepared solution was changed by changing 
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concentration. The results of this study showed that more viscous solutions tend to form 
nanofibers of bigger diameter size.  
The resulting nanofibers also showed that the incorporation of CA into the PLA nanofibers 
not only dramatically decreased their average diameter but also reduced the diameter 
distribution of electrospun nanofibers (see Table 4.1).  
Figure 4.1 and 4.2, show the SEM results of the drug-free and drug-loaded NFs at 
concentration ratio 3% w, respectively. SEM results for 1% and 5% drug ratios, 
incorporated in PLA NFs, are shown in the appendix. Both drug-free (Sample A, B, and 
C) and the drug-loaded PLA and PLA: CA (D, E, and F) nanofibers appeared smooth and 
no drug crystals were detected on the surface or outside the polymer. This suggested that 
the drug was homogeneously dispersed within the prepared fibers and reflected a good 
compatibility of the drug–polymer–solvent system.  Furthermore it was noticed that 
incorporation of the drug in the polymer solutions did not significantly affect the viscosity 
of the polymer solution, or decrease the mean diameter size of the resulting fibers (see 
Table 4.1).  
It was interesting to observe that all the composite electrospun nanofibers mats prepared in 
this study were desirably smooth and flexible. Such flexibility can provides easy handling 
and comfortable texture while using in medical application. 
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Table 4.1: Mean diameter size of the prepared nanofibers. 
 Range of 
diameter size 
(nm) 
Mean diameter size 
(nm) 
Viscosity of 
electrospun 
solution (mpas) 
Drug-free PLA: CA 
(7:3) NFs 
250-520 401±90 37 
Drug-free PLA: CA 
(9:1) NFs 
500-800 640±56 50 
Drug free PLA NFs 500-1200 850±91 61 
TQ-loaded PLA: CA 
(7:3) NFs 
200-520 390±45 35 
TQ-loaded PLA: CA 
(9:1) NFs 
520-800 623±101 48 
TQ-loaded PLA NFs 550-1000 830±82 59 
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Figure 4.1: Representative SEM images of the corresponding electrospun fiber mats, including 
histogram for the diameters of fibers (n≈100). (A-A’): drug free PLA: CA 7:3 NFs, (B-B’): drug-
free PLA: CA 9:1 NFs, (C-C’): drug-free PLA NFs 
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Figure 4.2: Representative SEM images of the corresponding electrospun fiber mats, including 
histogram for the diameters of fibers (n≈100). (D-D’): TQ-loaded PLA: CA 7:3 NFs, (E-E): TQ-
loaded PLA: CA 9:1 NFs, (F-F): TQ-loaded PLA NFs. 
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4.3 FT-IR characterization 
The chemical structure of the prepared films were investigated with the aid of |FT-IR. The 
samples investigated were, PLA: CA blend NFs (with ratio 7:3), TQ-loaded PLA: CA 
blend NFs and TQ-loaded PLA NFs. Such materials were chosen to show the chemical 
interaction between the two polymers and between the drug and polymers within the 
composite matrix. The chemical structure of the TQ, CA and PLA were also investigated 
(results are shown in the apendix). 
 
Figure 4.3 shows the FT-IR chart of the drug-free PLA: CA (7:3) scaffolds. Most of the 
characterestic peaks for both PLA and CA were observed. The broad peak at 3443 cm-1 
refers to the characteretic CA band for -OH stretching. It has been observed that the 
intensity of this characteresitic peak for CA has been reduced, compared to that in pure CA 
chart (see apendix). This can be attriuted to the existence of hydrogen bonding between the 
–OH of CA and the ester –C=O of PLA, resulting in the disappearance of the corrosponding 
IR peak. Such results demonstrate the existence of secondary interatcions between CA 
chains and PLA chains, which again could be a resaon for the decrease in viscoity 
associated with CA incoporportaion, as stated earlier.  The peak at 1217 cm-1 refers to the 
asymertric stretching of the ester bond (C-O-C) in the glycosidic linkage of CA [58]. On 
the other hand, the two peaks at 1361 and 1457 cm-1  and the sharp peaks at 2992 cm-1 
corrospond to the symmetric and asymmetric valence vibrations of -C-H from -CH3, 
respectively. The mountainous triplet peak at 1046, 1080, and 1132 cm-1 and peak at 1181 
cm-1 correspond to C–O stretching vibration of the PLA. Some of the peaks for both PLA 
and CA overlapped including the sharp, intense peak at 1755 cm-1 which is assigned to 
C=O stretching for both polymers. However, the value of this peak is somewhat shifted 
from the regular values assigned for the –C=O stretching of both PLA and CA (1749 cm-1 
for PLA and 1731 for CA) (see appendix) [26, 29,58].  
 
Figure 4.4 shows the FT-IR chart of the TQ-loaded PLA: CA (7:3) scaffolds. It is clear that 
the characterestic –OH peak, obsereved within the matrix, has been totally dimenished after 
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incoproration of TQ. This could be due to the formation of hydrogen-bonding between the 
–OH of the polymeric matrix and the –C=O of the drug, TQ. The characterestic peak for 
TQ has been observed at 1615 cm-1. This refers to the –C=C strecting in the 
cychexadiene,existing in the TQ structure. Also, broadening of some of the peaks has been 
observed including the peaks for –C=O at ( 1748 cm-1) [29,58]. The braod peak obtained 
includes the range of the characterestic –C=O of cyclohexadiene. Such observation could 
be due to the overlapping of different peaks together. Consequently as an IR spectrum is 
acquired, IR absorptions will occur at different frequencies for each of these bonds. The 
end result is that the IR peak appears broadened, as if it is an average of all these slightly 
different absorptions.  
For the TQ-loaded PLA NFs, all the characterestic peaks for PLA have been observed as 
discuused previously. The only characterestic feature for TQ-observed is the minor peak 
at 1650 cm-1 which refers to the –C=C strecting. This can reflect that TQ has been highly 
intrapped within the NFs and hiddened by the PLA features (Figure 4.5).  
 
 
Figure 4.3:  FT-IR chart of PLA: CA (7:3) NFs. 
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Figure 4.4: FT-IR chart of TQ-loaded PLA: CA (7:3) composite NFs. 
 
 
Figure 4.5:  FT-IR chart for TQ-loaded PLA NFs. 
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4.4 Porosity 
Figure 4.6 shows the relation between pore diameter and the corresponding pore surface 
area. This can provide an overview for the pore surface area distribution among the 
prepared scaffolds; TQ-loaded PLA, TQ-loaded PLA: CA 9:1 and TQ-loaded PLA: CA 
7:3. As shown in the figure, all the scaffolds featured mesopores (4-20 𝜇m) and macropres 
(50-150 𝜇m). However, the results indicated that the small pores (4-20 𝜇m) have the largest 
differential surface areas within the three prepared samples. This reflects that their numbers 
must be significant in the scaffolds. On the other hand, pores with large size posses 
differential surface areas of the least values, indicating their limited numbers. In 
conclusion, the smaller pores (4-20 𝜇m) accounted for most of the observed surface area 
in all the prepared scaffolds.  
 
 
Figure 4.6: Differential pore area vs. pore width for TQ-loaded PLA, PLA: CA 9:1 and PLA: 
CA 7:3 NFs 
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Figure 4.7 represents the pore size and pore size distribution of the prepared samples. The 
results of mean pore size diameter and porosity (%) are also summarized in Table 4.2. The 
results showed an increased trend in porosity with increasing CA concentrations. 
Furthermore, the pore size significantly decreased within the medicated PLA: CA 7:3 
composite scaffolds. Such pore size reduction can be attributed to the decrease in the fiber 
diameter after incorporation of CA into the matrix. As it was shown in the SEM results, 
CA-containing NFs showed smaller fiber diameters compared to that of PLA (Table 4.1). 
When the fiber diameter is small, more layers of fibers can overlap with each other. This 
can result in smaller pore diameter. Decreasing the pore size is considered an advantage 
when it comes to tissue engineering applications because it results in increasing the surface 
area. Consequently, it is expected that fibroblasts cells might attach and proliferate more 
effectively on PLA: CA 7:3 scaffolds compared to the medicated PLA scaffolds. 
 
 
Figure 4.7: Incremental intrusion volume of mercury versus pore diameter for TQ-loaded PLA, 
PLA: CA 9:1 and PLA: CA 7:3. 
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Table 4.2: Mean pore size and mean fiber diameter of medicated PLA, PLA: CA 9:1 and PLA: 
CA 7:3. 
Sample Mean pore 
size (um) 
Measured Porosity 
(%) 
Mean fiber 
diameter (nm) 
 
TQ-loaded PLA 
scaffolds 
 
4.857±0.01 
 
54% 
 
830±82 
 
TQ-loaded PLA: CA 
(9:1) scaffolds 
 
4.651±0.04 
 
63% 
 
623±101 
 
TQ-loaded PLA: CA 
(7:3) scaffolds 
 
4.201±0.02 
 
79% 
 
390±45 
 
4.5 Swelling behavior and water retention 
The percentages of water uptake of the medicated PLA, PLA: CA 9:1 and PLA: CA 7:3 
scaffolds are given in Table 4.3. It is clear from the results that the three fibrous scaffolds 
show significant capability for water uptake. The medicated PLA matrices showed a water-
absorbing capacity of 379 % after 24 h, whereas in medicated PLA: CA 9:1 and PLA: CA 
7:3 samples, the water absorbing capacity was 851.51 % and 1060 % respectively. Both 
medicated PLA: CA 9:1 and PLA: CA 7:3 mats absorbed much higher amount of water 
than the pure medicated PLA mats.  
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Table 4.3: Percentage of water up take capacity of TQ-loaded PLA, PLA: CA 9:1 and PLA: CA 
7:3 for 12, 24 and 48 hours. 
Time (h) TQ-loaded PLA 
scaffolds 
TQ-loaded PLA: CA 
(9:1) scaffolds 
TQ-loaded PLA: 
CA (7:3) scaffolds 
 
12 
 
247 ± 20.8 (%) 
 
555±35.5 (%) 
 
911± 18.9 
 
24 
 
379± 12.3 (%) 
 
851±27.8 (%) 
 
1060±11.8 
 
48 
 
1933±45.9 (%) 
 
2703±19.2 (%) 
 
3145±10.4 
 
 
The results showed that the water uptake increased with increasing CA content in the blend. 
This implies that the scaffolds became more hydrophilic upon incorporating CA. The 
prepared medicated PLA scaffolds is hydrophobic, because of the poor solubility of its 
components (PLA and TQ), thus it shows the lowest water uptake during a 48-h test period. 
On the other hand, CA, within scaffolds structure of the two other samples, (medicated 
PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 became slightly swollen upon contacting with 
PBS solution (Figure 4.8), because of its high solubility in water. This will leave tiny pores 
in the nanofibers within the fibrous mats, which is considered a desirable properties to the 
wound healing.  
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Figure 4.8: comparison between the swelling behavior of medicated PLA, PLA: CA 9:1 and 
PLA: CA 7:3. 
 
 
4.6 Water vapor permeability 
As it is shown in Table 4.4, the WVP values of all the developed medicated scaffolds were 
found to be in the specified range (16-19 g/m2/h). Figure 4.9 shows the change of weight 
gained (in grams) with time (in h) for the three prepared scaffolds. It is also noticed that by 
increasing the percentage of CA in the e-spun membranes, the permeability also increases 
(Figure 4.10). This indicates that the presence of CA has further improved the water vapor 
permeability of the membranes.  
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Table 4.4: Water vapor permeability of TQ-loaded PLA: PLA: CA 9:1 and PLA: CA 7:3, 
correlated to fiber diameter. 
Sample WVP (g/m2/h) Measured Porosity (%) 
Medicated PLA NFs 16.3±0.9 54% 
Medicated PLA: CA (9:1) 
NFs 
17.5±1.5 63% 
Medicated PLA: CA (7:3) 
NFs 
18.75±2.1 79% 
 
Such increase in WVP associated with CA incorporation can be attributed to two factors: 
First, is the hydrophilic nature of the CA. For polymer films, the water vapor permeability, 
(P), is the product of the solubility of polymer in the water, (S), and the diffusion coefficient 
of the water into the polymer, (D).  
 
P=SD 
The value of S is higher when the solubility parameter of the polymer and water are similar. 
Values of S, calculated by the group contribution method, are given in Table 4.5. As it is 
shown in the table, more hydrophilic polymers, such as CA, have higher values of S, 
compared to more hydrophobic polymers, such as PLA. CA has solubility parameter 25.7 
(J/Cm3), while amorphous and crystalline PLA have 21.5 (J/Cm3) [73]. This, in turn, will 
provide CA with higher water vapor transmission rate compared to PLA. Such 
phenomenon can be related to the significant hydrogen bonding interaction with water.  
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Table 4-5: Solubility parameter values for different polymer films [73]. 
Film Solubility parameter (J/Cm3) 
PLA (Crystalline) 21.7 
PLA (Amorphous) 21.7 
CA 25.7 
PCL 20.8 
 
Another reason for such increase in WVP associated with CA is the porosity and diameter 
size of the prepared scaffolds. Water vapor diffusion is highly dependent on air 
permeability of the membrane. Air permeability increases as the porosity of the membrane 
increases, which results in higher moisture transfer through the air voids [56]. It was clear 
from the SEM observation and porosity results that presence of CA has further decreased 
the fiber diameter, resulting in better permeability for water vapor (Table 4.4). 
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Figure 4.9: Water vapor gain vs. time for medicated PLA, PLA: CA 9:1 and PLA: CA 7:3 NFs 
 
 
Figure 4.10: Comparison between the medicated PLA, PLA: CA samples, showing the effect of 
CA on WVP. 
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4.7 In Vitro drug release study 
 
4.7.1 Calculation of total TQ content in the TQ-loaded NFs 
The drug loading efficiency within the prepared fiber mats was determined. Table 4.6 
summarizes the actual amount of TQ in each of the three samples (TQ-loaded PLA. TQ-
loaded PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 nanofibers mats). As shown in the table, 
high drug loading efficiencies were successfully achieved. This can be attributed to the 
lipophilic nature of the drug, TQ. During electrospinng, the solution jet rapidly elongates 
and the solvents evaporate quickly. If the drug is highly compatible with the 
electrospinning matrix/solvent system, phase separation would be difficult to take place 
and the drug tends to remain within the fiberous structure, where sufficient solvent is left. 
Thus when the nanofibers finally dry, the drug will be successfully encapsulated. Due to 
its lipohylicity and high solubility in all solvents used in the preparation of polymer 
solution (DCM: DMF), TQ appears to have high compatibility with the electrospinning 
system. The same conclusion has been achieved by Zeng et al during the fabrication of 
paclitaxel-loaded PLLA nanofibers [74]. Paclitaxel, a lipophilic drug, was highly 
incorporated in the nanofibers using PLLA/chloroform/acetone as the polymer/solvent 
system. 
 
It should be mentioned also that the prepared drug-loaded PLA and PLA: CA blend 
nanofibers displayed no significant differences in entrapment efficiencies among different 
regions alongside their constructs. 
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Table 4.6: Actual drug content and drug release % of TQ from the prepared nanofibers 
Sample Total drug content 
% 
Cumulative drug 
release %  
(24 hours) 
Cumulative drug 
release %  
(9 days) 
 
TQ-loaded PLA NFs 
 
90.49 ± 2.33 
 
17.7 
 
59 
 
TQ-loaded PLA: CA 
(9:1) NFs 
 
82.63 ± 6.89 
 
32.1 
 
69 
 
TQ-loaded PLA: CA 
(7:3) NFs 
 
79.51 ± 5.78 
 
55.9 
 
79 
 
 
 
4.7.2 Release profile of TQ from the TQ-loaded NFs 
For the prepared medicated scaffolds to exert their therapeutic functionality, the loaded TQ 
has to be released. The cumulative amount of TQ released from the medicated nanofibers 
is depicted in figure 4.12. The amount of drug finally released varied from one sample to 
another. Figure 4.11 indicated that the percentage of TQ released depends on the polymer 
composition in the fibrous matrix. The TQ released from medicated PLA NFs, medicated 
PLA: CA 9:1 and medicated PLA: CA 7:3 after 24 h were 17.7%, 32.1% and 55.9%, 
respectively. Afterwards, a gradual increase in the cumulative release followed over the 
next days to reach 59%, 69% and 79% for the medicated PLA, medicated PLA: CA (9:1) 
and medicated PLA: CA (7:3), respectively, after 9 days. Thus, it is clear that the addition 
of CA to PLA resulted in higher drug release.  
 
In our study, the dynamic of drug release from the scaffolds is controlled by their structure, 
which is represented by the ratio of polymer components in the matrix. It is concluded from 
the above data that the higher amounts of CA in PLA: CA 7: 3 matrix resulted in a burst 
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release of TQ during the first 24 h, followed by more sustained release of the drug for 9 
successive days 
 
 
Figure 4.11: Cumulative release of TQ from the prepared nanofibers matrices. 
 
This can be attributed to the hydrophilic nature of CA. Incorporation of CA into PLA 
nanofibers further improved the hydrophilicity of the matrix. This was proved by the higher 
swelling behavior and water retention capacity of CA-containing scaffolds. The higher the 
amount of CA, the higher is the swelling behavior of the scaffold. Such swelling increases 
fiber size and thus increases water content within the matrices, which enables more drug 
to diffuse through the network. These results correlate with the results obtained by Liu et 
al. In their study, the effect of addition of CA on the release of PHMB from polyester 
urethane (PEU): CA fiber mats was investigated. The 2:1 blend matrix showed higher 
release rate than their corresponding lower CA matrix [57]. In another study, the addition 
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PVP: PLLA nanofibers. After the first hour of release, more BSA was released from PVP-
containing e-spun fibers than that from the pure PLLA nanofibers [65].  
Another reason for such increase in drug release, associated with incorporation of CA is 
the size of fiber diameter. The morphological characterization of samples shows that CA 
incorporation resulted in significant decrease in the average fiber diameter.  A reduction in 
the average diameter of the nanofibers resulted in an increase in the surface-area-to-volume 
ratio of the nanofibers. Therefore, the tendency of the drug molecules absorbed on the 
surface to be released increased remarkably. 
 
The effectiveness of a certain drug is highly dependent on the rate of drug release from the 
NFs. For the delivery of antibiotic drugs, a large initial burst is considered an advantage 
because it is important to eliminate the intruding bacteria before they begin to proliferate. 
However, for the few organisms that may survive the initial burst, a continued release of 
antibiotic is also required to prevent their further population. Thus, it can be concluded that 
the electrospun PLA: CA 7:3 scaffold having 3% w of TQ exhibits an ideal release profile 
for potentially preventing infections associated with chronic and surgical wounds. 
 
Also, it is very interesting to notice the increase of drug release from the medicated PLA 
scaffolds after around 5-6 days. This can be attributed to the hydrolytic degradation of PLA 
(as discussed in the introduction, Section 5.1.4). Hydrolytic degradation of poly-lactide 
family proceeds through four stages (Figure 4.12): First, is the stage of water diffusion, 
followed by the second stage in which oligomers, with acidic group terminals, autocatalyze 
the hydrolysis reaction. In the third stage, oligomers start to diffuse out from the polymer 
while water molecules start to diffuse more into to the cavities created by the removal of 
the oligomers. This, in turn, encourage further oligomers diffusion. In this stage, marked 
decrease in polymer molecular weight occurs and a sharp increase in the drug release rate 
occur as the drug diffuses from the porous regions. Such decrease in polymer mass is 
associated with a sharp increase in the drug release rate, as the drug diffuses from the 
porous regions created in the matrix. In the fourth stage, polymeric matrix become highly 
porous and degradation proceeds homogeneously and more slowly [75, 76].  
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Figure 4.12: Schematic representation of hydrolytic degradation of poly-lactide polymers 
 
In general, the degradation rate of drug-loaded PLA matrix is highly dependent on the 
molecular weight of polymer and on the interaction between the polymer and drug. The 
impacts of these parameters that increase the degradation rate are not exactly clear [75, 76]. 
It could be the high molecular weight of the polymer used in our study and the way of 
physical interaction between the TQ and the PLA that resulted in such degradation pattern 
which further altered the release profile. 
 
4.8 In Vitro antibacterial assessment  
The drug under investigation, TQ, is known for its antibacterial properties against both 
Gram-negative and Gram-positive bacteria. In this work, the antibacterial activity of TQ-
loaded PLA and TQ-loaded PLA: CA composite nanofibers was investigated using the 
modified Kirby–Bauer method (disc diffusion method).  S. aureus and E.coli were used as 
a model for Gram positive and gram negative bacteria, respectively.  
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The medicated NFs discs were pasted onto the agar plate, seeded with the bacteria. The 
three prepared scaffolds, TQ-loaded PLA: CA (7:3), TQ-loaded PLA: CA (9:1) and TQ-
loaded PLA NFs discs and denoted as A, B, and C, respectively. Figure 4.13 and 4.14 show 
the inhibitory zone formation around the medicated NFs sample discs in agar plates of S. 
aureus and E. coli, respectively. It is clear that after incubation for 24 h, the agar regions 
with the medicated PLA: CA 9:1 and PLA: CA 7:3 scaffolds display visible bacterial 
inhibition rings. In contrast, medicated pure PLA mats did not show a significant bacterial 
inhibition effect.  This could be attributed to the slow cumulative release of TQ from the 
medicated PLA scaffolds for the first 8 h (13.3 %), compared to that of PLA: CA 9:1 and 
PLA: CA 7:3 (24.5% and 44.8 % respectively). The inhibition zone of medicated PLA: CA 
7:3 scaffold is the biggest, which should be attributed to the faster drug release rate and 
more TQ released from PLA: CA 7:3 than that from PLA: CA 9:1 nanofibers (Table 4.7).  
 
 
 
 
Table 4.7: Diameter of inhibition zones for the medicated nanofibrous mats. 
 
 
 
Medicated PLA: CA 
(7:3) scaffolds 
 
Medicated PLA: CA 
(9:1) scaffolds 
 
Medicated PLA 
scaffolds 
 
S. aureus 
 
3.3 ±0.1 cm 
 
2.8 ±0.2 cm 
 
0  
 
E. coli 
 
2.1 ±0.0 cm 
 
1.7 ±0.1 cm 
 
0  
 
 
 71 | P a g e  
 
It should be noted also that the inhibitory zones against S. aureus is larger than that against 
E. coli (Table 4.7). The main reason for this observation is that the activity of TQ against 
Gram-positive bacteria is more significant than that against Gram-negative ones. The 
minimum inhibitory concentration (MIC) of TQ for S. aureus and E. coli are 3 𝜇g/ml and 
800 𝜇g/ml, respectively. These results indicate that the encapsulated TQ drug within the 
PLA: CA scaffolds (at the two ratios used) is able to be released from the medicated 
nanofibrous mats and diffused onto the agar, thereby effectively inhibiting the bacterial 
growth. Consequently, medicated PLA: CA composite nanofibers could be effective in 
inhibiting the growth of bacteria and have the potential to be used in functional wound 
dressing and tissue engineering. 
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Figure 4.13:  Antibacterial activities of the TQ-loaded NFs mats against S.aureus. Sample A is 
TQ-loaded PLA: CA 7:3, Sample B is TQ-loaded PLA: CA 9:1 and Sample C is TQ-loaded PLA. 
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Figure 4.14:  Antibacterial activities of the TQ-loaded NFs discs against E-coli. Sample A is 
TQ-loaded PLA: CA 7:3, Sample B is TQ-loaded PLA: CA 9:1 and Sample C is TQ-loaded 
PLA. 
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4.9 Assessment of Cytotoxicity, cell proliferation and 
cell attachment  
 
 
4.9.1 Cytotoxicity assay: 
Figure 4.16 shows the cytotoxicities of the TQ-loaded PLA: CA 7:3, TQ-loaded PLA: CA 
9:1 and the TQ-pure PLA membranes as assessed by the MTT assay. The percentage of 
drug loaded is 3 % w Cytotoxicity results of another two drug loading percentage (1% and 
5% w) is included in the appendix.  It was found that the 5% drug loading resulted in a 
cytotoxic effect of mouse fibroblast, while the 1 and 3% did not show cytotoxic effect. 
However, 1% drug-loaded scaffolds did not show significant antibacterial activity (data 
not shown in the results). Thus, the 3% w drug loading was chosen for the preparation the 
scaffolds in this study.  
 
In the cytotoxicity examination, the extraction medium of the prepared scaffolds were used 
to evaluate their cytotoxicities against mouse fibroblast cells. The results indicated that no 
significant difference in absorption of pure culture medium and the extraction medium for 
all the prepared scaffolds. The extraction medium enabled cell viability of more than 97%. 
Also, the cell viability (%) for the 50%, 25% and 12.5% extracted solutions were similar 
to those for the 100% extracted solution. According to ISO 10993–5, these results indicate 
that the co-components of the prepared scaffolds are non-toxic and have excellent 
biocompatibility. Thus, the amount of TQ released at this point time from the three 
scaffolds are below the cytotoxic dose of TQ. 
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Figure 4.15: Cytotoxicity of electrospun TQ-loaded PLA, TQ-loaded PLA: CA 9:1 and TQ loaded 
PLA: CA 7:3 scaffolds.  
 
 
4.9.2 Cell proliferation and cell growth viability assay 
 
 
4.9.2.1 MTT assay 
The proliferation capacity of mouse dermal fibroblast (MDF) on the prepared electrospun 
scaffolds, medicated-PLA, medicated PLA: CA 9:1 and medicated PLA: CA 7:3, was 
determined. Figure 4.16 shows the proliferation results for 1, 3 and 7 days of cell culture, 
assessed by MTT assay. It was observed that the optical density of MDF on all the 
electrospun substrates increased during the 7 days of cell culture, which indicates that the 
HDF were metabolically active on the TQ-loaded scaffolds. These results correlated with 
the results obtained from the cytotoxicity analysis, which ensure the lack of cytotoxicity 
effect of the prepared scaffolds. Remarkable difference in cell proliferation was observed 
between days 3 and 7. The percentage increase in the rate of proliferation from day 3 to 
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day 7 on TQ-loaded PLA NFs, TQ-loaded PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 
nanofibrous scaffolds was found to be 23%, 41%, and 60%, respectively.   
 
 
Figure 4.16: Optical absorbance of mouse fibroblast cells seeded on TQ-loaded PLA, TQ-loaded 
PLA: CA 9:1 and TQ-loaded PLA: CA 7:3 scaffolds after 1, 3 and 7 days of incubation. 
 
In Figure 4.16, it can be seen that cells grown on each of the prepared scaffolds had equal 
or better cell proliferation than did cells grown on the two-dimensional control (two-
dimensional tissue culture polystyrene (PS) on days 3 and 7. This indicates that the cells 
on the nanofibers could migrate into the scaffolds thus allowing for more proliferation. 
This is attributed to the fact that cells have more area to grow in a 3-dimensional 
environment compared to the 2-dimensional one (Figure 4.17) [5]. Such 3-dimensional 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
1 day 3 days 7 days
A
b
so
rb
an
ce
 a
t 
5
7
0
 n
m
Control TQ-loaded PLA TQ-loaded PLA:  CA 9:1 TQ-loaded PLA: CA 7:3
 77 | P a g e  
 
environment resembles that of the natural extracellular matrix (ECM). On day 7, TQ-
loaded PLA: CA 7:3 scaffold showed a significantly higher proliferation and viability than 
other scaffolds and the two-dimensional tissue culture polystyrene. The same conclusion 
has been achieved by Sisson, et al. In their study, the results revealed that human 
osteosarcoma cell (MG63 cells) can grow and proliferate more on cross-linked gelatin NFs 
than the polystyrene tissue culture plate, used as a control [77].  
 
 
Figure 4.17: 3D structure of the NFs enhances cell binding and spreading [5]. 
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By comparing the cellular proliferation between the three prepared scaffolds, it is obvious 
that there is a negligible difference in cell viability after 1 day incubation. However, after 
3 days, the proliferation of MDF on the medicated PLA: CA 9:1 and PLA: CA 7:3 
nanofibers was found significantly higher than that on medicated pure PLA. We observed 
58% higher cell proliferation on TQ-loaded PLA: CA 7:3, compared to TQ-loaded PLA 
NFs after 7days of incubation. This can be due to the hydrophobicity of the PLA nanofibers 
surface and its TQ component.  
 
Thus, it can be concluded that the inclusion of CA within PLA scaffolds provides the 
scaffold with higher bioactivity and affinity for cell proliferation. This can be attributed to 
the fact that CA improves the hydrophilicity of the scaffolds, thus provide better cellular 
interaction. The same effect was also achieved by blending PLA with gelatin. As in a study 
done by Hoveizi1 et al, where modified PLA/gelatin 7/3 scaffold was proved to be more 
suitable for fibroblasts proliferation and that the cellular growth was significantly higher 
on the gelatin-blended nanofibers than the PLA, compared to PLA or gelatin NFs alone 
[66].  
 
4.9.2.2 Determination of viable cell suspension concentration 
The cell proliferation results were confirmed by the total cell count technique. Table 4.8 
represents the results of viable cells attached to the three different scaffolds after 1, 3 and 
7 days. After 3 and 7 days of cell culture, the number of fibroblasts attached on medicated 
PLA: CA 7:3 nanofibers was much higher than the cell attached to medicated PLA 
nanofibers. These results also confirmed the better adhesion and proliferation of fibroblasts 
on CA-containing scaffolds. From this data, one can clearly confirm the cell attachment 
and cell spreading in the NFs matrix. 
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Table 4.8: the total cell count of the mouse fibroblast on the medicated PLA, PLA: CA 9:1 and 
PLA: CA 7:3 NFs as reflection to the cell proliferation capability. 
  
TQ-loaded PLA 
scaffolds 
 
TQ-loaded PLA: CA 
(9:1) scaffolds 
 
TQ-loaded PLA: CA 
(7:3) scaffolds 
 
Day 1 
 
5×103 ± 6.36 
 
6×103± 11.23 
 
6×103± 8.98 
 
Day 3 
 
5×103± 10.12 
 
8×103± 7.90 
 
10×103± 7.61 
 
Day 7 
 
7×103± 8.01 
 
12×103± 5.96 
 
15×103± 10.43 
 
 
 
4.9.3 Assessment of cell attachment:  
To confirm the cellular regeneration, the morphological appearances of cells on composite 
NFs mats were investigated. Figure 4-18 and 4-19 shows the SEM images of cell 
attachment manner of the mouse fibroblast cells under static seeding on the medicated 
PLA, PLA: CA 9:1 and PLA: CA 7:3 after 3 and 7 days of culture, respectively. The SEM 
micrographs of fibroblasts showed a normal spindle shape morphology of cell growth on 
all the prepared NFs. After 3 days of cell culture, the number of fibroblasts attached on the 
medicated PLA: CA 9:1 and PLA: CA 7:3 nanofibers (Figure 4.18. A, 4.18. B, 
respectively) was significantly higher than the cell attached on PLA nanofibers (Fig. 4.18. 
C). After 7 days of cell culture, cells covered the available surface area on the PLA: CA 
9:1 and PLA: CA 7:3 nanofibers (Figure 4.19. H, 4.19. K, respectively). 
 
 The cells spread over the scaffold fibers, linked with fibers by cytoplasmic extensions. 
The presence of lamellapodia and an interlaced fibrous network indicated good cell 
adhesion. On the other hand, more empty nanofibers surfaces were observed for mediated 
PLA nanofibers with no lamellapodia formation. Thus, it was concluded that the cells were 
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well incorporated into the medicated PLA: CA composite nanofibers compared to the 
medicated PLA nanofibers. These results are in agreement with the results obtained from 
cell viability and proliferation, and confirmed that blending CA with PLA provides the 
scaffold higher cell affinity for skin tissue regeneration.  
 
The hydrophilic nature of the PLA: CA scaffolds is a reason for the observed better 
adhesion and proliferation of fibroblasts. Such conclusion was also reached by Unnithana 
et al. In this study, the authors blended dextran, hydrophilic polysaccharide, with 
polyurethane to prepare biocompatible scaffolds. The results indicated that the cells 
interacted favorably with the PU-dextran scaffolds better than the pure PU scaffolds. The 
higher bioactivity and cell affinity was attributed to the hydrophilic nature of the PU- 
dextran scaffolds [78].  Another reason for such behavior is the smaller fiber diameter 
and pore size associated with the CA-containing scaffolds. As it was explained 
previously in section 4.1 and 4.3, medicated PLA: CA scaffolds showed smaller fiber 
diameters and pore size as compared to medicated PLA scaffolds. Sun et al. studied the 
influence of fiber diameter, and pore-size on the behavior of human dermal fibroblasts. 
They assumed that smaller values of fiber diameter and inter-fiber space is necessary for 
cell adhesion, migration and for cell aggregate formation [3]. This can be attributed to the 
fact that the smaller the pore size and fiber diameter, the higher is the surface area 
available for cellular adhesion and proliferation.  
 
It is not only the hydrophilic nature of CA which resulted in such improved cellular affinity, 
also the biocompatible nature of CA played an important role. The extracellular matrix of 
cells (ECM), described earlier in the introduction, is consists of a nanosized network of 
biomolecules, such as proteins and glycosaminoglycans (polysaccharides) [5]. CA is a 
polysaccharide derivatives, thus it is similar in structure and composition to the 
glycosaminoglycans components of the ECM. Consequently, it can further allow the 
scaffolds to mimic the ECM, not only in the 3-D architecture, but also in chemical 
composition. 
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Another observation which is very interesting, is the lack of cellular infiltration. It is clearly 
noticed that the fibroblast cells migrate and adhered to the surface of the three prepared 
scaffolds, but did not penetrate inside the scaffold. This observation actually correlates with 
the data obtained from the pore size analysis (section 4.3). The results of pore size analysis 
indicated that the mean pore size for the three prepared scaffolds are ~ 4 𝜇m (4.857, 4.651, 
4.201 for medicated PLA, PLA: CA 7:3 and PLA: CA 9:1 NFs, respectively). The average 
size of fibroblast cells is (15-20 𝜇m) [3]. So, the pores within the scaffolds structure will 
not allow for cellular infiltration within the fibrous structure. Another reason for such poor 
cellular infiltration is the orientation of the NFs. It has been proved that aligned nanofibers 
significantly enhanced cell infiltration into the nanofibrous matrices in vitro, compared to 
the randomly oriented NFs.  
 
Such lack of cellular infiltration is considered an advantage when it comes to wound 
dressing materials. The ideal wound dressing should be able to promote fibroblast 
migration and proliferation within the wound bed, while preventing tissue ingrowth within 
the fibrous structure, in order to avoid tissue damage after dressing removal. 
 
 
 
 
 82 | P a g e  
 
 
Figure 4.18. Morphology of the mouse fibroblast on the prepared NFs; after 3 days of cell culture 
(a) TQ-loaded PLA: CA 7:3, (b) TQ-loaded PLA: CA 9:1, (c) TQ-loaded PLA.  
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Figure 4.19. Morphology of mouse fibroblast on prepared NFs; after 7 days of cell culture (D) 
TQ-loaded PLA: CA 7:3 (E) TQ-loaded PLA: CA 9:1 (F) TQ-loaded PLA. 
 
 
 
 
 
50 um 50 um 
50 um 
Lamellapodia 
formation 
Lamellapodia 
formation 
 84 | P a g e  
 
4.10 In Vivo wound healing test 
Wound healing is a special biological process that comprises four consecutive phases: (1) 
hemostasis and inflammation, (2) migration, (3) proliferation, and (4) tissue remodeling. 
It mainly requires more than 2 weeks between the time of injury and the complete 
fibroblast coverage on the surface of wound as a new skin layer. Owing to its 
antibacterial activity, and proliferation performance, TQ-loaded LA: CA (7:3) has been 
chosen for the in vivo study, in comparison to the TQ-loaded PLA scaffolds, to ensure 
the effect of incorporation of CA into the PLA scaffolds on the wound healing 
performance. The wound-healing properties of the prepared nanofibers mats were 
examined via an in vivo wound-closure assay on the dorsal wounds of mice. TQ-loaded 
scaffolds were used, together with gauze, as the control. The gross appearance of each 
wound was observed at 0, 7, 10 and 14 days of treatment. Figure 4.20 and 4.21 shows the 
representative macroscopic observation of each wound at the different healing times for 
the medicated PLA: CA (7:3), and medicated PLA scaffolds respectively. Also, the rate 
of wound closure as a function of time for both scaffolds is shown in figure 4.22 and 
4.23, respectively.  
 
After 7 days of treatment, more regenerated epidermis were observed for TQ-loaded 
PLA: CA scaffolds (Figure 4.20). Also, it is evident that re-epithelialization of the wound 
treated with TQ-loaded PLA: CA nanofibers was almost complete on day 10 while this 
stage took more than 14 days for the control wound. On day 14, a new layer of skin with 
almost no scarring was present on wounds treated with TQ-loaded PLA nanofibers. 
Starting from day 7 to day 14, TQ-loaded PLA: CA (7:3) composite scaffold did show 
faster contraction compared to the wound control, indicating the effect of the fibrous 
scaffold for promoting ECM formation and the delivery of TQ for preventing infection. 
Wound contraction can make the re-epithelialization easier [79]. On the other hand, 
figure 4.21 shows that there was no significant difference in wound appearance for both 
the wounds treated with medicated PLA scaffolds and the control wound for the first 7 
days. However, after 10 days of treatment, wounds treated with PLA NFs mat showed a 
significant increase in the rate of wound closure compared to the control. 
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Figure 4.20: Digital photograph assessment of healing progression from day 0 to day 14 for 
wounds treated with TQ-loaded PLA: CA (7:3) scaffolds vs. the control. (b) Representative mice 
with two wounds on its back for control and treated wounds after 7 days. 
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Figure 4.21: Digital photograph assessment of healing progression from day 0 to day 14 for 
wounds treated with TQ-loaded PLA scaffolds vs. the control. (b) Representative mice with two 
wounds on its back for control and treated wounds after 7 days. 
 
 
 
 
 87 | P a g e  
 
The rate of wound closure as function of time is represented in figure 4.22 and 4.23 for 
wounds treated with medicated PLA: CA (7:3) and medicated PLA scaffolds, 
respectively. The results showed that the wounds treated with the medicated PLA: CA 
(7:3) NFs mat showed a significant increase in the rate of wound closure compared with 
the control starting from day 7. On day 7, the closure rate of PLA: CA (7:3) treated 
wounds was almost 51 %, while only approximately 33.3 % wound closure was observed 
in the control samples (Figure 4.22). The wounds treated with TQ-loaded PLA: CA NFs 
mats healed much faster. It showed approximately 89 and 99 % wound closure on days 
10 and 14, respectively. 
 
On the other hand, wounds treated with a PLA NFs mat did not show a significant 
increase in the rate of wound closure compared to the control after 7 days of treatment 
(Figure 4.23). On day 10, the closure rate of wounds treated with PLA NFs mats started 
to show better performance compared to the control. It showed almost 67 % wound 
closure after 10 days, compared to the control which showed 50 % wound closure. This 
might be attributed to the slow release of TQ form the fibrous mats which can play a role 
in controlling the bacterial infection and invasion, thus allowing for better wound healing. 
Also, it could be attributed to the biocompatibility of PLA as well as the porous nature of 
NFs mats. The high surface area to volume ratio and the porous structure of NFs mats 
could maintain an ideal environment at the wound interface via absorption of exudates, 
gas and fluid exchanges, and bacterial protection.  
  
In a study done by Karami et al, the wound closure percentage of the electrospun 
PCL/PLA hybrid nanofibrous mats containing thymol, herbal drug, was more significant 
compared with those of the other dressings. The wound-closure percentages of the 
wounds treated with the electrospun PCL/PLA nanofibrous mats, and gauze bandages 
were 92.4, and 68%, respectively, after 14 days of treatment [80]. 
 
It is clear that the medicated PLA: CA (7:3) NFs mats enabled better wound healing than 
the control (gauze), while the medicated PLA NFs mats produced results similar to those 
for the control. In conclusion, TQ-loaded PLA: CA 7:3 scaffolds exhibited a faster 
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healing with more regenerated skin after 10 days, compared to the medicated PLA 
scaffolds. Such results actually correlate with the data obtained from the cellular 
proliferation and attachment assays, where the medicated PLA: CA (7:3) NFs composite 
showed better cellular response compared to the medicated PLA scaffolds. Another 
reason for such advanced performance in wound healing is the controlled drug release of 
TQ from the PLA: CA (7:3) scaffolds. The principal aim of treating wound infections is 
to reduce the bacterial load in the wound to a level at which wound-healing processes can 
take place. If the drug is released too quickly, the entire drug amount could be released 
before the infection is stopped. On the other hand, if the release of the drug is delayed, 
infection may set in further, thus making it impossible to manage the healing of the 
wound. The release of TQ from the PLA: CA (7:3) scaffolds showed highly controlled 
profile. It started with a sort of burst release of TQ, followed by the sustained release for 
almost 9 days. Such controlled release profile is similar to that of local antibiotics. For all 
local antibiotic release profiles should exhibit a high initial release rate in order to 
respond to the elevated risk of infection from bacteria introduced during the initial shock, 
followed by a sustained release at an effective level for inhibiting the occurrence of latent 
infection [37, 78, 79].  
. 
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Figure 4.22: Quantitative measurement for wound closure rate for wounds treated with PLA: 
CA (7:3) scaffolds vs. control. 
 
 
Figure 4.23: Quantitative measurement for wound closure rate for wounds traeted with PLA 
scaffolds vs. control. 
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5. Conclusion and Future prospective 
 
5.1 Conclusion 
Many biocompatible polymers have been used to generate nanofibers. Biopolymers proved 
to be the most biocompatible polymers, thus they are widely used in tissue engineering and 
wound dressing applications. PLA is considered a very promising biopolymer, owing to its 
renewability, bioavailability and inexpensive price as compared to petroleum based 
polymers. However, one of the main issues which limit the wide application of PLA in 
tissue engineering purposes is the high hydrophobicity and lack of cellular interaction. 
Thus, by modifying its properties, poly-lactic acid (PLA) may prove to be a very promising 
biomaterial.  
 
In this study, modification of PLA was achieved by blending it with cellulose acetate (CA). 
CA is a polysaccharide with high hydrophilicity and better cellular response than PLA. 
PLA: CA nanocomposite scaffolds was prepared by the electrospinning technique. 
Polymer solutions of both PLA and CA, at the ratios PLA: CA 9:1 and 7:3 was electrospun 
to prepare NFs scaffolds that can be further used as a wound dressing material. For the aim 
of achieving an interactive wound dressing scaffolds, an antibacterial agent was also 
introduced in the scaffolds to avoid bacterial infection. The antibacterial agents used for 
this study was Thymoquinone, an active ingredient of Nigella sativa.  TQ is widely used 
due to its antibacterial properties. The drug was used in the ratio 3% w based on the weight 
of polymer. The obtained scaffolds were characterized for its morphological, chemical, 
physical (Porosity, swelling behavior &water vapor permeability) and biological (in vitro 
drug release, antibacterial activity, cytotoxicity and cellular proliferation) properties. 
 
The results showed that the incorporation of CA within the PLA matrix altered the 
chemical and physical properties of the scaffolds. It resulted in scaffolds of smaller fiber 
diameters and smaller pore size, compared to that of PLA NFs. As well as, the 
incorporation of CA resulting in higher water vapor permeability and swelling behavior for 
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the scaffolds. Such alteration can be justified by the hydrophilicity of the CA and its ability 
to form hydrogen bonding. It’s the hydrogen bonding between CA and PLA, as shown by 
FT-IR analysis that decreased the viscosity of the polymer solution, which further resulted 
in fibers with smaller diameters. The hydrogen bonding of CA with water resulted into 
improving the water uptake capacity of the membranes and increased its WVP. 
Furthermore, hydrohplicity of CA has altered the release profile of the TQ from the 
prepared scaffolds. TQ-loaded PLA: CA 7:3 scaffolds showed a kind of burst release, when 
compared to the TQ-loaded PLA scaffolds, followed by a stable sustained release for 
almost 9 successive days. After 24 hours of incubation in modified PBS medium, 
approximately 56% of TQ was released from the TQ-loaded PLA: CA (7:3) scaffolds, 
compared to 18% released from the TQ-loaded PLA scaffolds. Such burst release is 
considered an advantage for controlled delivery of an antibacterial agent, because it is 
expected to prohibit the initial bacterial growth while the subsequent sustained release will 
prevent further proliferation of bacteria. This was further proved by the antibacterial 
assessment of the scaffolds. Medicated PLA: CA scaffolds showed a significant 
antibacterial activity against S. aureus and E.coli, assessed through the agar diffusion 
technique. On the other hand, medicated PLA scaffolds failed to show any antibacterial 
inhibition zone, attributed to the delayed drug release from the medicated PLA scaffolds. 
Incorporation of CA into the PLA matrix has further improved the biological performance 
of the scaffolds. Medicated PLA: CA scaffolds showed better cellular response, regarding 
biocompatibility and cellular proliferation when compared to medicated PLA scaffolds. 
This can be attributed not only to the improved hydrophilicity of the prepared scaffolds, 
but also to the biocompatible nature of CA, as one of the polysaccharides derivatives. Such 
conclusion was also confirmed via in vivo wound healing evaluation assay. In the in vivo 
study, medicated PLA: CA (7:3) scaffolds showed faster wound healing progress in 14 
days (approximately 100% wound closure rate) compared to the control. 
 
In this study, blending technique provided a simple, while effective method to modify the 
properties of PLA to be more suitable for biomedical applications. Thus, we can claim that 
the prepared TQ-loaded PLA: CA scaffolds are very promising antibacterial scaffolds that 
can be used effectively as an interactive wound dressing material.  
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5.2 Future prospective 
A future prospective for the e-spun TQ-loaded PLA: CA NFs in wound care includes: 
 Introducing the scaffold in a clinical trial to ensure its functionality 
 
 Utilizing the scaffolds in the development of smart devices. A smart device refers 
to a multi-component system that can deliver multiple therapeutic benefits in a 
single product. In this regard, TQ, as an antibacterial agent, can be used in junction 
with a vascular endothelial growth factor (VEGF). Such multi-component scaffolds 
typically accelerate the wound healing process by promoting angiogenesis and 
further inhibit bacterial infection. 
 
 Utilizing prepared matrix as a bioactive indicator for monitoring the progression of 
healing and/or bacterial load. This can be achieved by incorporating a sensor within 
the electrospun scaffolds, thus allowing the real-time detection of specific 
parameters from the wound bed. The sensor generates a visible output for the 
patient or the doctor to provide continuous monitoring of the wound status. There 
is a range of potential markers and parameters associated with wound healing and 
infections that can be detected.  The pH is considered the most reliable marker for 
the healing process. Chronic non-healing wounds have an elevated alkaline pH. 
However, healing occurs more readily in an acid environment. Consequently, 
monitoring wound surface pH may provide a method of ‘measuring’ the condition 
of the wound bed and eventually aid in determining the wound’s response to 
treatment. pH biosensor TQ-loaded PLA: CA wound dressing can be prepared by 
immobilizing pH sensitive dyes into the NFs. 
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7 Appendix 
 
Calibration curves: 
 
 
TQ Calibration curve in DCM: DMF 
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TQ calibration curve in PBS 
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SEM results 
 
 
TQ-loaded PLA NFs at drug loading ratio 1 wt. % 
 109 | P a g e  
 
 
TQ-loaded PLA NFs at drug loading ratio 5 wt. % 
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FT-IR charts 
 
 
FT-IR chart for CA powder 
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FT-IR chart for neat PLA NFs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 112 | P a g e  
 
Cytotoxicity 
 
 
Cytotoxicity results of TQ-loaded PLA NFs at the drug ratios 1, 3 and 5 wt. % 
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